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The lipid kinase P13K plays key roles in cellular responses to activation of 
receptor tyrosine kinases or G protein coupled receptors such as the 
metabotropic glutamate receptor (mGiuR). Activation of the PI3K catalytic 
subunit p11 0 occurs when the PI3K regulatory subunit p85 binds to 
phosphotyrosine residues present in upstream activating proteins. In addition, 
Ras is uniquely capable of activating PI3K in a pBS-independent manner by 
binding to p11 0 at amino acids distinct from those recognized by p85. Because 
Ras, like p85, is activated by phosphotyrosines in upstream activators, it can be 
difficult to determine if particular PI3K-dependent processes require p85 or Ras. 
Here we ask if PI3K requires Ras activity for either of two different PI3K-
regulated processes within Drosophila larval motor neurons. To address this 
question, we determined the effects on each process of transgenes and 
chromosomal mutations that decrease Ras activity, or mutations that eliminate 
the ability of PI3K to respond to activated Ras. We found that P13K requires Ras 
activity to decrease motor neuron excitability, an effect mediated by ligand 
activation of the single Drosophila mGiuR DmGiuRA. In contrast, the ability of 
PI3K to increase synaptic bouton number is Ras independent. These results 
suggest that distinct regulatory mechanisms underlie the effects of PI3K on 
distinct phenotypic outputs. We additionally found that the glutamate-activation 
of DmGiuRA initiates ERK signaling; however the signaling intermediates linking 
DmGiuRA to this kinase cascade are unknown. 
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Chapter 1 : Introduction and Background 
1.1 Significance 
Cognitive function requires the formation and refinement of neural 
connections. The capacity of synapses to adapt in response to stimuli, called 
synaptic plasticity, which involves the strengthening or weakening of a synapse, 
is widely believed to be the mechanism underlying the retention of information in 
the brain, thus crucial for learning and memory (Davis, 2006; Martinet al., 2000; 
Bliss and Collingridge, 1993). Many neurological disorders, including the autism 
spectrum disorders (ASD)s, are thought to arise from imbalances in the 
excitatory and inhibitory processes of synaptic transmission that regulate 
synaptic plasticity (Rubenstein and Merzenich, 2003). 
Recently, the phosphoinositide 3-kinase (PI3K) signaling pathway, most 
notable for its role in insulin-signaling and its effects on cellular growth and 
survivability (reviewed in Engelman et al., 2006), has emerged as a key mediator 
of the functionality and establishment of neural circuits. Hyperactivated PI3K 
signaling has recently been found to participate in the etiology of several 
neurological diseases that have co-morbidity with autism, including 
Neurofibromatosis 1 (NF1 ), tuberous sclerosis {TSC), and Fragile X Syndrome 
(FXS) (Kalkman, 2006; Levitt and Campbell, 2009; Serajee et al., 2003; Butler et 
al., 2005; Kwon et al., 2006; Mills et al., 2007). Therapeutics that have targeted 
the PI3K signaling pathway have proven useful in the treatment of cancer 
(Morgensztem and Mcleod, 2005), therefore elucidating the molecular signaling 
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components that regulate PI3K activity in neural tissues may be additionally 
useful for the design of new treatments for neurological disease. 
1.2 Phosphoinositide 3-kinase (PI3K) is involved in a multitude 
of cellular processes 
1.2.1 The biochemistry of PI3K 
PI3K functions by specifically phosphorylating the 3' -hydroxyl of the inositol 
ring of intracellular phosphatidylinositol (Ptdlns), Ptdlns 4-phosphate (PI4-P), and 
Ptdlns(4,5)-biphosphate (PI(4,5)P2 or PIP2)(Panayotou, 1998) (Fig.1 ). The 
phosphorylation of these inositol lipids into phosphoinositides (PI)s, particularly 
the second messenger Ptdlns(3,4,5)P3 (PIP3), by PI3K is crucial for many cellular 
processes including cell growth and survival, the rearrangement of the 
cytoskeleton, membrane trafficking, and transcription (Lemmon, 2008; Hurley, 
2006; Di Paolo and De Camilli, 2006; Roth, 2004; Brunet et al., 2001 ). The 
multiple isoforms of PI3K present in eukaryotic organisms are divided into three 
classes (class 1-111) based on their structure, substrate specificity, and mode of 
regulation (Vanhaesebroeck et al., 1997). The class I PI3Ks are involved in cell-
signaling downstream receptor tyrosine kinases and heterotrimeric G protein-
coupled receptors (GPCRs) and are the focus of this study. The class II and 
class Ill PI3Ks are involved in G-protein beta-gamma subunit (Gev) activation and 
intracellular protein trafficking, respectively (MacDougall et al., 1995; Stephens et 
al., 1994; Schu et al., 1993). These classes of PI3K are beyond the scope of this 
work and will not be discussed here. 
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The vertebrate class I PI3Ks are heterodimers consisting of two subunits; a 
1 ,068 AA catalytic subunit, called p11 0, and an adaptor protein, p85, which 
contains two Src homology domains (SH2) linked by an inter-SH2 region 
(Vanhaesebroeck et al., 2001; Panayotou, 1992). Three isoforms of p11 0 
(p110a, p110j3, p110y) and seven associated adaptor proteins (generated from 
the alternate splicing of p85a, p85j3, and p55y) have been identified in mammals 
(Vanhaesebroeck and Alessi, 2000). Drosophila has only one class I PI3K, 
Dp110 (MacDougall et al., 1995), and a single, SH2-domain-containing adaptor 
protein, p60 (Weinkove et al., 1997). 
The adaptor protein links the p11 0 catalytic subunit to different upstream 
signaling events via the binding of proteins that contain a phosphotyrosine in a 
Y(P)xxM motif (i.g. receptor tyrosine kinases) (Vanhaesebroeck et al., 2001; 
Vanhaesebroeck et al.,1997). The binding of the adaptor protein to the 
appropriate phosphotyrosine target subsequently recruits p11 0 to the membrane 
where interaction with the membrane-associated Ptdlns substrates can occur 
(Vanhaesebroeck et al., 1997). 
1.2.2 Overview of the PI3K signaling cascade 
The specificity of PI3K in the activation of these various processes is 
mitigated by the engagement of a variety of effector molecules. Most notably is 
the serine/threonine kinase Akt (also known as protein kinase B, PKB). Akt 
contains an N-terminal pleckstrin homology (PH) domain that preferentially binds 
PIP3 (James et al., 1996; Stephens et al., 1998). PIP3 recruits Akt to the 
membrane, altering its conformation, enabling a second serine/threonine kinase, 
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phosphoinositide-dependent kinase-1 (PDK1 ), to phosphorylate and activate Akt 
(Thr308 in vertebrates and Thr505 in Drosophila) (Stephens et al., 1998; Alessi 
et al., 1997) (Fig.1.1 ). Activated Akt targets several substrates that are involved 
in growth and cell-cycle regulation including the forkhead box transcription factor 
(FOXO) (Puig et al., 2003) and the tuberous sclerosis complex (TSC1/2) (Potter 
et al., 2001 ). FOXO is a negative regulator of cellular growth and an activator of 
apoptosis (Junger et al., 2003; Paik et al., 2007). Phosphorylation of FOXO via 
Akt is inhibitory, thus P13K signaling decreases FOXO activity, releasing the cell 
from FOXO-dependent growth inhibition. As a negative regulator of PI3K 
signaling, the phosphatase and tensin homologue (PTEN) opposes the activity of 
P13K by preferentially dephosphorylating PIP3 (Chu and Tamawski, 2004) 
(Fig.1.1) 
PI3K-Akt signaling regulates translation via mammalian target of rapamycin 
(mTOR) (Hay and Sonenberg, 2004; lnoki et al., 2002). The phosphorylation of 
TSC2 of the TSC1/2 complex by activated Akt inactivates the mTOR complex 
(lnoki et al., 2002). The TSC1/2 complex primarily functions as a GTPase-
activating protein for Ras-homolog enriched in brain (Rheb) which directly 
activates mTOR; therefore, the inactivation of TSC1/2 allows Rheb to stimulate 
mTOR complex activity (Long et al., 2005; Sanack et al., 2007). The mTOR 
complex, consisting of two multi-protein complexes: mTOR complex 1 
(mTORC1) and mTOR complex 2 (mTORC2), is a regulator of cell growth, 
proliferation, cell survival, and translation (Laplante and Sabatini, 2009) mTORC1 
promotes protein synthesis by phosphorylating the eukaryotic initiation factor 4E 
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Figure 1.1: Overview of the PI3K signaling cascade. Class I PI3K molecules 
are typically activated by receptors that induce tyrosine kinase activity, insulin 
receptors, and G protein-coupled receptors. PI3K phosphorylates the inositol ring 
of phosphatidylinositol 4,5-biphosphate (PIP2), producing the second messenger, 
phosphatidylinositol 3,4,5-triphosphate (PIP3). The activity of PI3K is negatively 
regulated by phosphatase and tensin homolog (PTEN). PIP3 recruits the 
serine/threonine kinase Akt to the membrane via the N-terminal pleckstrin 
homology domain of Akt, altering the conformation of Akt which enables a 
second kinase, phosphoinositide-dependent kinase-1 (PDK1 ), to phosphorylate 
and activate Akt. Activated Akt negatively regulates the activity of the 
transcription factor, forkhead box transcription factor (FOXO). Activated Akt 
additionally inactivates the tuberous sclerosis complex (TSC1 /2), which functions 
as a GTPase for Ras-homolog enriched in brain (Rheb ). Inactivation of TSC1 /2 
allows Rheb to activate the mammalian target of rapamycin (mTOR) complex. 
The mTOR complex promotes translation by phosphorylating and thus inhibiting 
the eukaryotic initiation factor 4E (eiF4E) binding protein (4E-BP1) complex, 
which allows the initiation factor eiF4E to bind and promote translation. mTOR 
additionally activates the ribosomal protein S6 kinase (S6K) which further 
enhances mRNA translation (reviewed in Vanhaesebroeck et al., 2001 ). 
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(eiF4E) binding protein (4E-BP1) and p70 S6 kinase (S6K). The phosphorylation 
of 4E-BP1 prevents it from binding eiF4E, enabling eiF4E to promote cap-
dependent translation of ribosomal proteins (Hay and Sonnenberg, 2004 ). The 
phosphorylation of S6K by mTOR1 enhances the translation of 5' terminal 
oligopyrimidine tract-containing (5'-TOP) mRNAs (Dufner and Thomas, 1999; 
Jefferies et al., 1997). The regulation of 4E-BP1 as well as p70 S6K are crucial to 
neural processes, including those that govern synaptic plasticity (Antion et al., 
2008; Gelinas et al., 2007; Banko et al., 2006), and the inappropriate regulation 
of mTOR signaling has been implicated in many human diseases including 
autism (Sabatini, 2006; Dann et al., 2007). 
1.2.3 PI3K is involved in neural outgrowth processes 
Changes in nervous system architecture have been linked to neurological 
dysfunction and are often hallmarks of mental retardation (Meredith and 
Mansvelder, 201 0; Ess, 2006). PI3K is widely recognized as a principle 
intermediary of cellular growth and metabolism, and has recently emerged as a 
key mediator of synaptic growth, therefore influencing connectivity in the brain 
(Kwon et al., 2006). In cultured neurons, P13K signaling is required for the 
outgrowth of neurites, which are neural protrusions that can differentiate into 
either axons or dendrites, in response to growth factors such as nerve growth 
factor (NGF) (Kimura et al., 1994). Neurite outgrowth can be blocked by the 
application of specific PI3K inhibitors and the overexpression of PI3K is sufficient 
to promote neurite outgrowth and elongation in the absence of NGF (Zheng et 
al., 2011; Kita et al., 1998). 
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PI3K signaling is additionally required for the outgrowth and morphogenesis 
of differentiated dendrites and axons. Factors that regulate dendritic growth, 
including Reelin, the epidermal growth factor CALEB/NGC, and Semaphorin-40, 
have been found to influence dendritic complexity through the PI3K-Akt-mTOR 
pathway in the rat hippocampus (Jossin and Goffinet, 2007; Brandt et al., 2007; 
Vodrazka et al., 2009). Constitutively active PI3K, Akt, or the inhibition of PTEN 
have all been found to increase dendritic growth and to alter dendrite morphology 
(Jaworski et al., 2005; Kumar et al., 2005; Luikart et al., 2008). Axon growth in 
response to growth factors, including NGF and brain-derived neurotropic factor 
(BDNF), also requires PI3K signaling (Zhou et al., 2004; Tucker, 2002; Atwal et 
al., 2000). The PI3K effector Akt has also been found to be enriched in the 
growth cones of developing hippocampal axons (Shi et al., 2003). 
Pharmacological inhibition of PI3K or the expression of the PTEN in cultured 
hippocampal cells prevents axon elongation (Shi et al., 2003; Menager et al, 
2004; Jiang et al., 2005; Yoshimura et al., 2006). PI3K mediates the effects on 
neurite outgrowth via the regulation of the Rho GTPases, Cdc42 and Rac1 (Aoki 
et al., 2004; Luo et al., 2002) and additionally regulates axon growth cones by 
influencing microtubule dynamics (Akiyama and Kamiguchi, 201 0; Rodgers and 
Theibert, 2002). 
1.2.4 PI3K is also involved in neural function via the regulation of two 
forms of synaptic plasticity: Long-term potentiation and long-term 
depression 
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As previously mentioned, synaptic plasticity is widely believed to be crucial for 
learning and memory (Davis, 2006; Martin et al., 2000; Bliss and Collingridge, 
1993). There are two defined forms of plasticity: "short-term" and "long-term" 
plasticity that are based on the period of time that the change in activity modifies 
the function of the neuron. Short-term plastic phenomena, which include 
facilitation (an increase in the release of vesicles from a vesicle pool within the 
pre-synapse) and augmentation (when an action potential increases the 
efficiency at which neurotransmitters are released), are temporary changes in 
activity that are quickly rectified by the neuron returning back to its "resting state" 
(Stevens and Wesseling, 1999). Long-term plasticity results from extended 
periods of altered synaptic activity that generally occurs after the repeated 
stimulation of the neuron (Bliss and Lomo, 1973). Long-term potentiation (L TP) 
and long-term depression (LTD), forms of long-term synaptic plasticity that 
involve an increase or decrease in synaptic strength, respectively (Citri and 
Malenka, 2008), are triggered by synaptic activity in the brain (Bear, 1998) and 
require an increase in transcription (Kang and Schuman, 1996; Huber et al., 
2000). These forms of plasticity generally occur at excitatory synapses and are 
thought to underlie the processes that govern cognitive function (Davis, 2006; 
Martinet al., 2000; Bear, 1998; Bliss and Collingridge, 1993). 
PI3K signaling is involved in the establishment of both L TP and L TO which 
has been primarily studied in the excitatory synapses of the CA 1 region of the 
vertebrate hippocampus (Bear and Malenka, 1994; Bliss and Collingridge, 1993). 
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L TP occurs when multiple synapses are simultaneously activated at a high 
frequency, resulting in the depolarization of the post-synaptic cell in conjunction 
with the release of the excitatory neurotransmitter, glutamate, from the pre-
synaptic neuron (reviewed in Nicoll and Malenka, 1995). This combination results 
in the activation of the post-synaptic ionotropic glutamate receptors (iGiuRs), a-
amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) and N-methyl-0-
aspartate (NMDA), which sensitizes the postsynaptic cell to further stimulation. 
PI3K has been found to co-localize with AMPA receptors and is required for the 
insertion of these receptors in to the post-synaptic membrane during the 
induction of L TP (Man et al., 2003). PI3K signaling is also required for the 
maintenance of L TP in the post-synapse by regulating translation via mTOR and 
p70 S6K (Karpova et al., 2006). 
LTD is also mediated by the activation of synaptic NMDA receptors 
(Dudek and Bear, 1992) or by second type of glutamate receptor, the 
metabotropic glutamate receptor (mGiuR) (Gladding et al., 2009) (Fig.1.2). Unlike 
L TP, LTD results in the de-sensitization of the post-synaptic cell occurring in 
response to a prolonged, low frequency stimulation. L TO can be initiated via the 
entry of Ca2+ through NMDA receptor channels or by the activation of mGiuRs on 
the post-synaptic cell (discussed in more depth in the following section) 
(Malenka, 1995; Gladding et al., 2009). PI3K signaling couples the activation of 
mGiuR to dendritic protein translation which is required to sustain L TO (Hou and 
Klann, 2004 ). 
glutamate 
oo 0 
O ca2 NMDA 
Long-term 
potentiation (L TP) 




depression (L TO) 
(low frequency stimulation) 
NMOA receptor-l TO and mGiuR-l TO 
are mutually exclusive or can act 
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ceil type (Gladding et al., zoot) 
Figure 1.2: Long-term potentiation (L TP) and long-term depression (L TO) 
modify synaptic activity. (A) L TP is induced by high-frequency electrical 
stimulation resulting in postsynaptic depolarization. Depolarization removes Mg2+ 
from the NMDA receptor channel, which allows glutamate binding to permit Ca2+ 
to enter in to the cell through the channel. Ca2+ activates a series of signal 
transduction cascades that regulate the insertion of the AMPA receptor into the 
postsynaptic membrane via the activity of protein kinases. Membrane insertion of 
additional AMPA receptors increases the sensitivity of the postsynaptic cell to 
glutamate. The maintenance of later phases of L TP requires the translation of 
proteins involved in making new synaptic contacts. (B) LTD is induced by long 
periods of low-frequency electrical stimulation that also results in the activation of 
NMDA receptors, resulting in Ca2+ entry into the postsynaptic cell. The rise in 
Ca2+is slower compared to the rise in Ca2+ during L TP and activates a series of 
phosphatases that are associated with the internalization of AMPA receptors 
from the membrane. Loss of the AMPA receptors decreases the sensitivity of the 
postsynaptic cell to glutamate. LTD is also mediated by the glutamate-activation 
of mGiuRs, called mGiuR-L TD. During this form of LTD, the activation of the 
group I mGiuRs initiates a series of signal transduction cascades that regulate 
transcription. This form of LTD can be independent or work synergistically with 
NMDA receptor-LTD depending on the cell type. (Note: This overview reflects 
L TP/L TD in vertebrate hippocampal neurons. These processes differ in other 
neural cell types). (Reviewed in: Purves, D. , et al., eds. Neuroscience, 4 th ed. 
Massachusetts, Sinauer Assoc. Inc., 2008.) 
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1.2.5 Aberrant PI3K signaling is observed in neurological diseases that 
have co-morbidity with autism 
Abnormalities in the regulation of excitatory synapses, altering the initiation 
and maintenance of L TP and LTD, have been linked to autism (Rubenstein and 
Merzenich, 2003). Aberrant PI3K signaling has been linked to a number of 
significant neurological diseases that have co-morbidity with autism, including 
Fragile X Syndrome (FXS), tuberous sclerosis (TSC), and Cowden/Lhermitte-
Ducols syndrome (Bourgeois et al., 2009; Kelleher and Bear, 2008). The 
affected genes in FXS (fragile X mental retardation protein, FMR1), TSC 
(tuberous sclerosis complex 1 and 2, TSC1/2), and Cowden/Lhermitte-Ducols 
syndrome (phosphatase and tensin homolog, PTEN), encode negative regulators 
of the PI3K pathway (Gross et al., 201 0; Levitt and Campbell, 2009; Kelleher and 
Bear, 2008; Williams et al., 2008; Kwon et al., 2006). Interestingly, gene copy 
number variants discovered in individuals with autism spectrum disorders (ASD) 
involve genes that affect the PI3K signaling pathway that are predicted to elevate 
PI3K activity (Cusc6 et al., 2009). The mTOR inhibitor, rapamycin, is currently 
being used clinically as an immunosuppressant for organ transplants and for 
psoriasis (under the brand name Rapamune®, Wyeth Pharmaceuticals); 
however its use as for treatment for FXS and these other disorders that involve 
abnormal PI3K has been limited (reviewed in Ehninger and Silva, 2010). 
Rapamycin has been useful for the treatment of the tumors that form in 
association with TSC (Davies et al., 2008); however, the effect of this drug on 
cognition and neurological symptoms are still underway (de Vries, 2009). 
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Identifying additional components of the PI3K signaling pathway involved in the 
PI3K-mediated effects on synaptic plasticity may prove useful for the 
development of more effective therapeutics. 
1.3 Metabotropic glutamate receptors are crucial for synaptic 
processes 
1.3.1 Metabotropic glutamate receptors mediate synaptic plasticity by 
regulating neuronal excitability 
In addition to the iGiuR, another receptor type that is crucial to the regulation 
of excitatory synapses is the metabotropic glutamate receptor (mGiuR). The 
mGiuRs are G protein-coupled receptors and unlike the iGiuRs are considered to 
be involved in "slow'' synaptic transmission through the activation of second 
messengers (Ferraguti et al., 2008; Conn and Pin, 1997; Gerber et al., 2007). 
The mGiuRs function to modulate neuronal excitability and are involved in the 
feedback regulation of neurotransmitter release (Schoepp, 2001 ; Ferraguti and 
Shigemoto, 2006). 
The mGiuRs can be categorized into three groups (group 1-111) based on 
sequence homology and their associated downstream signaling components 
(Schoepp, 2001; Conn and Pin, 1997). In general, group I mGiuRs (Gq-coupled) 
activate Ca2+ transients via a phospholipase-C (PLC)- inositol triphosphate (IP3) 
receptor dependent pathway (Fig.1.3). The group 111111 mGiuRs (Gi/Go coupled) 
are negatively coupled to adenylyl cyclase and inhibit the formation of cyclic 
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adenosine monophosphate (cAMP) (Fig.1.3) (Gerber et al., 2007; Conn and Pin, 
1997). Group I mGiuRs are commonly found on the postsynapse (Baude et al., 
1993) and group 11/111 are localized both pre- and postsynaptically (Shigemoto et 
al., 1997). In particular, the group II mGiuRs function as autoreceptors by 
detecting excess glutamate that has diffused out of the synapse during high-
frequency synaptic activity (Bogdanik et al., 2004; Lujan et al., 1997; Shigemoto 
et al., 1997). The activation of group II mGiuRs by glutamate initiates a negative-
feedback signal that suppresses the additional release of glutamate by the 
neuron, thus controlling the strength of synaptic transmission and reducing the 
risk of glutamate toxicity (Vogt and Nicoll, 1999; Conn and Pin, 1997; Scanziani 
et al., 1997). This suppression is thought to occur via the inhibition of voltage-
dependent Ca2+ channels, the activation of K+ channels, or by interfering with 
vesicle exocytosis (Takahashi et al., 1996; Scanziani et al., 1995). 
Many neurological disorders, including anxiety disorders, epilepsy, and 
schizophrenia are considered to be disorders of glutamatergic synaptic 
transmission (Enz, 2007; Chapman et al., 1996). Coincidentally, alteration in 
mGiuRs or mGiuR signaling is implicated in a number of these same diseases 
(Enz, 2007). The implication that mGiuRs may participate in these disorders 
makes investigating mGiuR signaling an attractive area of study for the 
development of potential therapeutic targets (reviewed in Byrnes et al., 2009; 









Figure 1.3: Overview of the group 1/111 metabotropic glutamate receptor 
(mGiuR) signaling cascades. mGiuR activation initiates G protein activity that 
increases or decreases the activation of downstream kinases. (Top) Group 11/111 
mGiuRs generally have pre-synaptic localization and are primarily coupled to 
Gailo· Activation of group 111111 mGiuRs suppresses adenylyl cyclase activity, 
reducing cyclic AMP (cAMP) levels and protein kinase A (PKA) activity. (Bottom) 
Group I mGiuRs are expressed primarily on postsynaptic sites and are linked to 
Gaq. The activation of group I mGiuRs activates phospholipase C (PLC) to 
generate diacylclycerol (DAG) and inositol 1.4.5-triphosphate (IP3), leading to a 
release of Ca2+ from intracellular stores. DAG additionally simulates protein 
kinase C (PKC) activation. Another type of glutamate receptor, the ionotropic 
glutamate receptor (iGiuR), is additionally found on postsynaptic sites and 
regulates fast-synaptic transmission. These receptors are comprised of the 
AMPA and NMDA receptors (reviewed in Kim et al., 2008; Schoepp, 2001 ). 
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1.3.2 mGiuRs mediate L TP and LTD via the regulation of translation 
The mGiuRs are involved in the establishment of both L TP and LTD 
(Holscher et al., 1999; Altinbilek and Manahan-Vaughan, 2009; Manahan-
Vaughan, 1997). The induction of LTD by mGiuRs, termed mGiuR-L TD, requires 
the activation of the postsynaptic group I mGiuRs as well as an increase in 
intracellular calcium (Ca2+) (Kieppisch et al., 2001; Oliet et al., 1997; Shigemoto 
et al., 1997). mGiuR-LTD results in a persistent decrease in post-synaptic AMPA 
receptors and the rapid translation of pre-existing dendritic mRNA, which 
increases protein synthesis in localized areas at or around dendritic spines 
(Huber et al., 2000; Job and Eberwine, 2001; Raymond et al., 2000; Karachot et 
al., 2001 ). Work from several groups has established that the Extracellular 
signal-related kinase/Mitogen-activated protein kinase (ERKIMAPK) and mTOR 
signaling pathways couple mGiuR activation to translational machinery during 
both LTP and LTD (Gladding et al., 2009; Banko et al., 2006; Gallagher et al., 
2004; Hou and Klann, 2004; Sweatt, 2004). The post-synaptic scaffolding 
protein, Homer, forms a signaling complex with group I mGiuRs to couple these 
receptors to the ERK and PI3K signaling cascades (Rong et al., 2003; Ronesi 
and Huber, 2008) and is a specific requirement for the initiation of translation 
during mGiuR-L TD (Ronesi and Huber, 2008). 
Recently, a role for the presynaptic group II mGiuRs in the establishment of 
LTD has also been identified. Pharmacological inhibition of group II mGiuRs 
abolishes LTD in hippocampal neurons and results in spatial learning defects in 
rats (Aitinbilek and Manahan-Vaughan, 2009). The group II mGiuRs lack the 
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Homer-binding motif (Diagana et al., 2002) and the molecular mechanisms 
linking this receptor subtype to LTD are not clear. The altered expression of 
group II mGiuRs have been suggested to contribute to the pathophysiology of 
schizophrenia and epilepsy (Gupta et al., 2005; Aronica et al., 1997); therefore 
analysis of the signaling intermediates is of interest to human health. 
1.3.3 Aberrant mGiuR and PI3K signaling appear to be involved in the 
etiology of Fragile X Syndrome 
Overactive group I mGiuR signaling, which results in abnormal L TO, has been 
implicated in epilepsy, cognitive impairment, and developmental delay (reviewed 
in Bear et al., 2004). Enhancement of mGiuR-LTD has been observed in a 
mouse model of the human neurological disorder, Fragile X Syndrome (FXS) 
(Koekkoek et al., 2005; Huber et al., 2000). FXS is the most common form of 
inherited mental disability resulting from a loss-of function mutation in the gene 
encoding the Fragile X mental retardation protein (FMRP), which in humans is 
generally caused by the expansion of a CGG repeat sequence in the 5' 
untranslated region of the fragile X mental retardation 1 (FMR1) gene (Garber et 
al., 2006; Bagni and Greenough, 2005; Feng et al., 1995). Patients exhibit a wide 
range of neurological deficits including cognitive impairment, seizures, attention 
deficits, and autism (Penagarikano et al., 2007). FMRP normally binds and 
represses the translation of mRNAs that are translated during mGiuR-L TO 
(Banko et al., 2006; Weller et al., 1997), therefore loss of FMRP activity is most 
likely responsible for enhancement of mGiuR-L TD observed in models of FXS 
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(Pfeiffer and Huber, 2009; Nosyreva and Huber, 2006; Muddashetty et al., 2007; 
Weiler et al., 2004). 
New evidence indicates that loss of FMRP results in the dysregulation of the 
PI3K signaling pathway. It was previously demonstrated that the de novo protein 
synthesis required for the establishment of mGiuR-L TD involves the mGiuR 
initiation of the PI3K-Akt-mTOR cascade (Hou and Klann, 2004 ). Fmr1 knockout 
(KO) mice, used as models for FXS, exhibit elevated S6K and 4E-BP activity, 
indicative of increased mTOR signaling (Sharma et al., 2010). Additionally, PI3K 
and the upstream activator PI3K enhancer (PIKE) are enhanced in Fmr1 KO 
mice (Sharma et al., 2010). Loss of FMRP in KO mice also results in the excess 
mRNA translation of the catalytic subunit of PI3K, p11 013, and that the basal 
enzymatic activity of P13K was increased threefold in FXS synapses (Gross et 
al., 2010). Application of pharmacological inhibitors to cultured neurons that 
antagonize PI3K signaling corrects several phenotypes associated with FXS, 
including aberrant synaptic translation and excess spine density, suggesting that 
the PI3K signaling cascade may be a useful target for therapeutics (Grosset al., 
2010). 
1.4 The effects of PI3K signaling on synaptic plasticity may 
involve Ras 
1.4.1 Ras, a GTPase, is an activator of PI3K 
PI3K appears to be a critical regulator of both neural form and function and 
PI3K-pathway components may prove to be useful targets for the treatment of 
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neurological disorders such as ASD. Though it has been suggested that group I 
mGiuRs may activate PI3K via a complex with the the scaffolding protein Homer 
(Ronesi and Huber, 2008) additional activators that link P13K to group II mGiuRs 
or to the synaptic growth-associated effects of PI3K activation have not been 
elucidated. One well-studied mechanism involves the receptor-tyrosine kinase 
activation of phosphotyrosines that activate PI3K via the regulatory subunit p85 
(Pignataro and Ascoli, 1990). In addition to this route, PI3K can also be activated 
in a pBS-independent manner by the monomeric guanosine triphosphatase 
(GTPase), Ras. 
Ras, a member of a large family of membrane-associated GTPases, is an 
essential mediator of intracellular signaling, transducing extracellular messages 
from the cell membrane to within the cell (Giehl, 2005; Malumbres and Barbacid, 
2003; Barbacid, 1987). Ras is well-known for its role in cell proliferation, 
differentiation, survival, and cell death and gain-in-function mutations in ras 
genes are closely associated with tumorigenesis (Giehl, 2005; Malumbes and 
Barbacid, 2003; Bos, 1989). Ras cycles between an active conformation (GTP 
binding) and an inactive conformation (GOP binding) and the switch between 
these two forms can be regulated by the activity of two families of proteins; the 
guanine exchange factors (GEFs), which enhance the activity of Ras, and the of 
GTPase-activating proteins (GAPs) that reduce Ras activity (Bernards and 
Settleman, 2004 ). 
Ras functions through a series of downstream signaling cascades. The most 
notable effectors include the serine/threonine kinase Raf, Ral, and the class I 
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PI3K molecules (Fig.1.4 ). The Ras-Raf-Mitogen Activated Protein Kinase 
(MAPK; the MAPK family which also includes Extracellular signal-Regulated 
Kinase, ERK) signaling pathway is the best-characterized signaling cascade 
most-often involved in the cellular growth-related effects associated with Ras 
(Malumbres and Barbacid, 2003) (This pathway is discussed in more depth in 
Chapter 4 ). Perturbations in this effector pathway have also been implicated in 
numerous neurological disorders including Noonan, Costello, and cardio-facio 
syndromes (reviewed in Schubbert et al., 2007). 
PI3K is also a well-studied Ras effector (Orme et al., 2006; Rodriguez-Viciana et 
al., 1994). Activated Ras binds to a specific Ras-binding domain (RBD) in the in 
the catalytic unit of PI3K, inducing a conformation change that modifies the 
phosphoinositide headgroup binding site that activates the kinase activity of PI3K 
(Rodriguez-Viciana et al., 1996). Activation by Ras has been suggested to be a 
requirement for the full activation of PI3K (Rodriguez-Viciana et al., 1996; Kodaki 
et al., 1994; Rodriguez-Viciana et al., 1994). Similar to PI3K, Ras is involved in 
synaptic plasticity and aberrant Ras activity results in alterations of synaptic 
outgrowth (Fivaz et al., 2008; Oinuma et al., 2007; Kumar et al., 2005; Jarwoski 
et al., 2005; Govek et al., 2005; Markus et al., 2002) LTD and LTP (Ye and 
Carrew, 2010; Hu et al., 2008; Arendt et al., 2004); however, it is unclear to what 
extent Ras and PI3K interact in these processes. 
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Figure 1.4: Overview of Ras effector cascades. Ras activation is initiated by 
the activation of several receptor types, including receptor-tyrosine kinases and 
G protein-coupled receptors. Activated Ras initiates multiple signal transduction 
cascades involved in a variety of cellular activities (note: the above list of effector 
molecules is not exhaustive). The two most critical in regards to this study are the 
PI3K and Rat effector pathways. Ras binds to a specific Ras-binding domain in 
the catalytic unit of PI3K, which activates PI3K. Activated Ras also activates the 
serine-threonine kinase Raf, that then activates the mitogen-activated protein 
kinase kinase (MEK). MEK phosphorylates and activates extracellular signal-
related kinase (ERK), which is involved in the activation of transcription factors 
(reviewed in Malumbres and Barbacid, 2003). 
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1.4.2 Ras, like PI3K, is involved in synaptic plasticity and is associated 
with several significant neurological diseases 
Ras signaling is involved in the modulation of synaptic structure. Ras has 
been identified in developing axons (Fivaz et al., 2008), and similar to PI3K, Ras 
overexpression has been demonstrated to increase both axon and dendrite 
outgrowth in both cultured cells and in vivo (Markus et al., 2002, Kumar et al., 
2005; Jarwoski et al., 2005; Oinuma et al., 2007; Romero et al., 2007); whereas 
down-regulating Ras prevents dendritic spine maturation (Govek et al., 2005). 
Overexpression of Ras has additionally been found to modify axon thickness in 
the neurons of the vertebrate corpus callousm (Arendt et al., 2004) and Ras 
activity is additionally required for the growth and elongation of axons in 
response to growth factors such as nerve growth factor (NGF) (Markus et al., 
2002; Zhou et al., 2004). 
Similar to PI3K, Ras and the Ras family proteins appear to be critical for 
memory formation via the modification of L TP and LTD (reviewed in Ye and 
Carrow, 201 0). A role for Ras in the establishment of L TP was found in mouse 
models of the human disease Neurofibromatosis-1 (NF1 ). NF1, which results 
from the mutation of the Ras-GAP encoding gene, neurofibromatosis 1 (NF1) (Xu 
et al., 1990), is characterized by skeletal abnormalities, abnormal skin 
pigmentation, and tumors of the peripheral nerves (reviewed in McClatchey, 
2007). These growth defects are suspected to be the result of hyperactivated 
Ras signaling (McClatchey et al., 2007; Gottfried et al., 2010). Patients with NF1 
are also often diagnosed with learning disabilities and ASD that may be related to 
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the perturbations in L TP (Kelleher and Bear, 2008; Silva et at., 1997; Costa et al., 
2001; Costa et al., 2002; Costa et al., 2005; Li et al, 2005; North et al., 2002). 
The injection of pharmacological inhibitors of Ras restores the abnormal L TP and 
memory defects observed in mouse models of NF1 indicating that in addition to 
the aberrant cellular growth effects, Ras is also facilitating changes in synaptic 
function (Costa et al., 2002; Li et al., 2005). 
Though the hyperactivation of both Ras and PI3K have been observed in 
disorders related to autism, the possibility that they may be functioning in a 
similar pathway has not been carefully explored. One recent report suggests that 
Ras-PI3K signaling may be involved in L TP in mouse models of FXS (Hu et al., 
2008). A significant reduction in L TP was observed in FMR1 KO mice that 
correlated with the aberrant delivery of AMPA receptors to the post-synaptic 
membrane of hippocampal neurons (Hu et al., 2008). Similar to PI3K, Ras has 
been previously shown to be involved in the synaptic delivery of AMPA receptors 
to the post-synaptic membrane (Malinow and Malenka, 2002; Isaac et al., 2007), 
and it was found that the L TP defect could be restored by overexpressing 
wildtype Ras in these neurons (Hu et al., 2008). The rescue of L TP by Ras was 
blocked by the application of the PI3K pharmacological inhibitor, L Y294002, 
indicating that Ras is acting on the AMPA receptor via PI3K (Hu et al., 2008). 
1.4.3 Ras is positioned to activate both the ERK and PI3K signaling 
cascades: is Ras a requirement for PI3K-mediated effects on synaptic 
growth and function? 
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Ras is positioned to activate both the ERK and PI3K cascades and it is not 
always clear if the effects of Ras on cellular function are via the activation of only 
one or both of these effector pathways. Deciphering the downstream activity of 
Ras has been important for the treatment of human cancers. Interestingly, the 
activation of either the Ras-ERK or PI3K pathways appears to confer differing 
resistance to chemotherapeutic drugs in cancer cells. For example, in breast 
cancer cells, the activation of Ras-ERK provides resistance to doxorubicin and 
paclitaxel; whereas the activation of PI3K provides resistance to doxorubicin and 
4-hydroxyl tamoxifin (reviewed in McCubrey et al., 2006). However, in prostate 
cancer cells, the PI3K pathway, but not the Ras-ERK pathway, is involved in drug 
resistance (McCubrey et al., 2006). These findings indicate that in different 
tumor types that these pathways may have distinct roles in the progression of 
oncogenesis. Understanding which of the Ras-effector pathways is altered under 
different oncogeneic conditions is critical for the application of effective cancer 
treatments. Therefore elucidating the specific activation of Ras-ERK or Ras-PI3K 
in the nervous system may also be useful for the treatment of nervous system 
disorders. 
In the vertebrate nervous system, the ERK and PI3K cascades have been 
observed to function cooperatively to regulate neuron outgrowth; however, each 
pathway has also been found to have a differential effect on growth (Kumar et al., 
2005; Jaworski et al., 2005; Arendt et al., 2004; Koh et al., 2002; Markus et al., 
2002). The activation of Ras and the ERK and PI3K pathways is required for 
axon growth in cultures of dorsal root ganglion neurons; however, the activation 
24 
of Ras-ERK is primarily responsible for axon elongation whereas PI3K signaling 
is involved in the soma size and axon branching (Markus et al., 2002). Similarly, 
in cultured hippocampal cells, Ras activation facilitates dendrite outgrowth via the 
ERK and P13K effector pathways and PI3K activation is also specifically involved 
in the size of the cell body and dendritic branching (Jaworski et al., 2005; Kumar 
et al., 2005). In the pyramidal neurons of the hippocampus, soma size depends 
on Ras-ERK signaling (Arendt et al., 2004), whereas Ras-ERK signaling is 
critical for dendrite outgrowth (Kumar et al., 2005). These studies clearly indicate 
that the ERK and PI3K pathways play distinct roles in the modification of neural 
and synaptic structure; however, pharmacological inhibitors that block PI3K 
signaling by targeting PI3K effectors were utilized to block PI3K signaling, so it is 
unclear to what extent Ras may be required for PI3K-mediated affects on neural 
growth. 
Though it is well-established that PI3K participates in NMDA receptor-
mediated L TP and mGiuR-L TD, much less is known about the role of PI3K in 
pre-synaptic group II mGiuR-mediated signaling. Our lab has recently found that 
the activation of the ortholog of the vertebrate group II mGiuR in Drosophila 
initiates PI3K signaling in the larval motor neuron (Howlett et al., 2008); however 
it is unclear how these receptors activate PI3K. Numerous other G-coupled 
protein receptors are known to directly or indirectly activate Ras (reviewed in 
Goldsmith and Dhanasekaran, 2007), indicating that Ras may function as an 
mGiuR-PI3K signaling intermediate. Deciphering the Ras-independent and Ras-
dependent PI3K-mediated processes as they relate to synaptic outgrowth and 
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neural plasticity may prove useful for the treatment of significant neurological 
diseases. 
1.5 Examination of Ras-dependent and Ras-independent 
activation of PI3K in neural processes in Drosophila 
1.5.1 The Drosophila neuromuscular junction is an effective model to 
study neural function 
The larval neuromuscular junction (nmj) of Drosophila has emerged as a 
useful model system for the study of synaptic function and development because 
of its relative simplicity, accessibility, and because it can be manipulated by a 
multitude of genetic techniques. The Drosophila nmj has been useful in the study 
of glutamatergic synapses (Bogdanik et al., 2004, Petersen et al., 1997; Schuster 
et al., 1991), neural development (Packard et al., 2003), and has also proven to 
be a useful system for electrophysiological studies (Peron et al., 2009; Jan and 
Jan 1976). Several forms of short-term synaptic plasticity, such as facilitation 
and post-tetanic potentiation and depression, as well as LTD have been 
demonstrated to occur at the neuromuscular junction (Guo and Zhong, 2006; Wu 
et al., 2005; Jan and Jan, 1978) making the Drosophila nmj a useful model to 
study the processes that govern synaptic plasticity. 
1.5.2 Similar to what has been found in vertebrate systems, P13K and 
Ras have been found to modify synaptic growth and activity in Drosophila 
Our lab and others have previously examined the role of PI3K and Ras on 
various aspects of synaptic growth in Drosophila. The overexpression of Ras 
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and PI3K in the larval nmj was previously demonstrated to significantly increase 
axon arborization at the larval nmj (Koh et al., 2002; Martin-Peiia et al., 2006; 
Howlett et al., 2008). The overexpression or knockdown of PI3K in the motor 
neuron also increases and decreases axon diameter, respectively (Howlett et al., 
2008). Our lab recently found that the effects of PI3K on growth are via the 
mTORIS6K effector pathway (Howlett et al., 2008). Koh et al., (2002) indicated 
that the Ras-ERK signaling cascade was principally responsible for synaptic 
outgrowth; however, it is unclear if Ras activation is additionally responsible for 
the PI3K-mediated effects on neural growth. 
1.5.3 The activation of the Drosophila mGiuR regulates excitability via 
PI3K in the motor neuron 
Drosophila possesses one functional mGiuR-family protein, Drosophila 
metabotropic receptor A (DmGiuRA). Based on sequence analysis and its 
pharmacological profile, DmGiuRA is most similar to the vertebrate group II 
mGiuRs (Parmentier et al., 1996). DmGiuRA has been identified presynpatically 
on the axons of the larval motor neurons in regions adjacent to the active zones 
of the neuron, suggesting that similar to the vertebrate group II mGiuR, it may 
function like an autoreceptor (Bogdanik et al., 2004; Zhang et al., 1999). A null 
mutant of DmGiuRA, DmG/uRA 112b, previously generated via transposon 
excision, exhibits several neural defects (Bogdanik et al., 2004). The larval 
motor neurons exhibit a "hyperexcitable" electrophysiological phenotype when 
electrical stimulation is applied to the motor neuron. Additionally, the axons 
innervating larval nmjs have fewer branches and slightly enlarged synaptic 
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boutons (the boutons are round structures found on axon termini involved in the 
secretion of neurotransmitters) (Bogdanik et al., 2004). Our lab found that motor 
neuron excitability could be altered by the modulation of the P13K signaling 
pathway and that the DmG/uRA 112b hyperexcitability phenotype could be 
suppressed by expressing constitutively-active PI3K transgene (P/3K-CAAX) in 
the motor neuron (Howlett et al., 2008). We additionally found that the 
application of the mGiuR ligand, glutamate, to Drosophila larval preparations 
results in a significant increase of phosphorylated-Akt (p-Akt), a product of PI3K 
signaling. The same effect was not observed when glutamate was applied to 
either DmG/uRA 112b or to larvae expressing a DmGiuRA RNA-interference (RNAi) 
transgene (Howlett et al., 2008). These data indicate that activated DmGiuRA 
initiates PI3K signaling in the Drosophila motor neuron (Howlett et al., 2008). 
To our knowledge, this is the first demonstration of the activation of PI3K by a 
group II mGiuR. The group I mGiuRs have been proposed to activate PI3K 
through the Homer scaffolding protein and the PI3K enhancer PIKE (Rong et al., 
2003; Ronesi and Huber, 2008); however, the group II mGiuRs, including 
DmGiuRA, lack the Homer binding motifs (Digana et al., 2002) therefore are not 
predicted to activate PI3K via this mechanism. 
1.5.4 The goal of this study is to delineate which neural processes are 
governed by the Ras-dependent/independent activation of P13K in the 
Drosophila motor neuron 
Because Ras is positioned to activate both the ERK and PI3K signaling 
cascades, it is not clear which PI3K-dependent neural processes require either 
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Ras or p85-mediated activation. Using the Drosophila nmj, we have examined if 
PI3K requires Ras activity in several PI3K-regulated processes: synaptic 
outgrowth, axon diameter size, the activation of PI3K by DmGiuRA, and the 
modulation of motor neuron excitability. To this end we examined the effect of 
decreasing Ras activity using transgenes, chromosomal mutations, and a PI3K 
variant is not responsive to Ras-activation on each of these processes. We found 
that PI3K requires Ras activity to activate PI3K in response to the ligand-
activation of DmGiuRA. In addition, we found that Ras is required for the effects 
of PI3K on motor neuron excitability. Ras is however not required for the effects 
of PI3K on either synaptic growth or axon diameter. These results demonstrate 
that there are distinct regulatory mechanisms controlling the effects of PI3K on 
the growth and function of neurons which may have important implications to the 
neurological diseases that occur as a result of alterations to synaptic plasticity. 
Chapter 2: The activation of PI3K by DmGiuRA is a 
Ras-dependent process 
2.1 Introduction 
2.1.1 The Drosophila mGiuR may function as an autoreceptor 
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Synaptic plasticity is governed by the "strengthening" and ''weakening" of 
synaptic connections via changes in neural excitability (Davis, 2006; Katz and 
Shatz, 1996; Bliss and Collingridge, 1993). Neural excitability is in part mediated 
by the secretion of neurotransmitters that alter the generation of action potentials 
(Lipton and Kater, 1989). Glutamate is the principal excitatory neurotransmitter in 
the vertebrate brain and up to 40% of all synapses are glutamatergic (van den 
Pol et al., 1990). Glutamate can be highly toxic to neurons in a condition called 
excitotoxicity where excess synaptic glutamate can literally "over-stimulate" 
nerves to death (Sucher et al., 1997); therefore, the release and uptake of 
glutamate is tightly regulated (Meldrum, 2000). 
The metabotropic glutamate receptors (mGiuRs) are G protein coupled 
receptors primarily involved in the mediation of the neuron's response to and the 
additional release of glutamate (Schoepp, 2001; Ferraguti and Shigemoto, 2006). 
mGiuRs are sub-divided into three groups based on their sequence homology 
and downstream signaling components (Schoepp, 2001 ). The postsynaptic 
group I mGiuRs are involved in the establishment of both L TP and L TO (Holscher 
et al., 1999; Altinbilek and Manahan-Vaughan, 2009; Manahan-Vaughan, 1997). 
The role of this mGiuR subtype in the facilitation of L TO has been the primary 
focus of a majority of studies examining mGiuR-L TO (reviewed in Gladding et al., 
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2009). The group 11/111 mGiuRs, principally located on the presynaptic neuron 
and on the glia (in the case of group Ill), appear to primarily function as 
autoreceptors by negatively regulating glutamate or y-aminobutyric acid (GABA) 
synaptic transmission (Schoepp, 2001 ). The group II mGiuRs were recently 
found to regulate LTD in the hippocampus in response to both electrical and 
pharmacological-induced LTD (Poschel and Manahan-Vaughan et al., 2005; 
Altinbilek and Manahan-Vaughan, 2009), however the downstream signaling 
components involved their regulation of this process have not been identified. 
Drosophila possesses one functional mGiuR-family protein, Drosophila 
metabotropic glutamate receptor A (DmGiuRA) that is most similar to the 
vertebrate group II mGiuRs (Parmentier et al., 1996). Consistent with the 
vertebrate group II mGiuRs, DmGiuRA is located adjacent to the active zones of 
the pre-synapse where it is postulated to function as a glutamate autoreceptor 
(Bogdanik et al., 2004; Zhang et al., 1999). A null mutant of DmGiuRA, 
DmG/uRA 112b, exhibits normal, basal synaptic transmission; however when high 
frequency stimulation is applied, the motor neurons become hyperexcitable 
(Bogdanik et al., 2004; Howlett et al., 2008), indicating a failure in the capacity of 
these neurons to regulate their activity. 
2.1.2 PI3K participates in glutamate-activated DmGiuRA signaling in the 
Drosophila motor neruon 
Our lab has previously shown that PI3K is important for the regulation of 
Drosophila motor neuron excitability (Howlett et al., 2008). We found that the 
expression of a constitutively-active PI3K transgene ( UAS-P/3K-CAAX) in the 
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motor neuron causes a hypoexcitable, neural phenotype and that knocking down 
PI3K activity with either a dominant-negative PI3K transgene ( UAS-P/3~N) or by 
expressing the PI3K inhibitor, PTEN, results in motor neuron hyperexcitability 
(Howlett et al., 2008). We determined that the hyperexcitable phenotype 
observed in the DmG/uRA112b mutant (Bogdanik et al., 2004) was the result of 
reduced P13K signaling (Howlett et al., 2008). We demonstrated that the 
activation of DmGiuRA in the larval motor neuron by the application of glutamate 
causes an increase in the levels of phosphorylated-Akt (p-Akt), a product of PI3K 
activation. This effect was not observed when glutamate was applied to either 
DmG/uRA 112b or to larvae expressing a DmGiuRA RNA interference (RNAi) 
transgene. We additionally found that we could rescue the DmG/uRA 112b 
excitability defect by expressing UAS-P/3K-CAAX in motor neurons, indicating 
that P13K is epistatic to DmGiuRA (Howlett et al., 2008). The PI3K-mediated 
effect on neural excitability was determined to be the result of the downregulation 
of Drosophila FOXO (dFOXO) (Howlett et al., 2008) (Fig.2.1 ). Though the direct 
targets have yet to be identified, we suspect that dFOXO alters excitability by 
modulating the transcription of ion channel subunits or regulators (Howlett et al., 
2008), or by targeting the translational repressor Pumilio (Schweers et al., 2002). 
To our knowledge this is the first demonstration of the activation of PI3K by a 
group II mGiuR and it may prove to be relevant to mGiuR signaling in 
vertebrates. 
DmGiuRA 




Figure 2.1: The activation of DmGiuRA initiates PI3K the signaling cascade 
to downregulate neural excitability. Our lab previously determined that the 
ligand-activation of DmGiuRA initiates PI3K signaling and that this activation is 
critical for the regulation of motor neuron excitability. PI3K phosphorylates and 
converts PIP2 to PIP3, recruiting the serine/threonine kinase Akt to the membrane 
via the N-terminal pleckstrin homology domain of Akt altering the conformation of 
Akt which enables the kinase PDK1 to further phosphorylate and activate Akt 
(reviewed in Vanhaesebroeck et al., 2001 ). Activated Akt negatively regulates the 
activity of the transcription factor dFOXO. The downregulation of dFOXO 
decreases neural excitability in the motor neuron (Howlett et al., 2008). The 
mechanisms by which dFOXO decreases excitability are not currently known; 
however, we postulate that the transcription of ion channel subunits or regulators 
may be involved. 
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2.1.3 The signaling pathway linking DmGiuRA to PI3K has not been 
fully uncovered 
As discussed in the Introduction, the group I mGiuRs may interact with the 
scaffolding protein Homer to initiate the PI3K cascade (Rong et al., 2003; Ronesi 
and Huber, 2008). This interaction is critical for the regulation of translation 
during mGiuR-L TD (Ronesi and Huber, 2008); however, it has not been 
conclusively demonstrated that the mGiuR-Homer interaction activates PI3K. 
Additionally, the group II mGiuRs, which are most similar to DmGiuRA, lack the 
Homer binding motif (Diagana et al., 2002), therefore the mechanism by which 
activated DmGiuRA is initiating the PI3K cascade is not immediately clear. 
It was previously reported that the Calcium/calmodulin-dependent kinase II 
(CaMKII) and the Drosophila ortholog of the nonreceptor tyrosine kinase Focal 
adhesion kinase (DFak) are involved in the regulation of Drosophila neuronal 
excitability in the motor neuron (Griffith et al., 1994; Park et al., 2002; Ueda et al., 
2008). Because DmGiuRA additionally modifies motor neuron excitability 
suggests that CaMKII and DFak may function in a pathway similar to DmGiuRA. 
In fact, our lab has now demonstrated that CaMKII and DFak are necessary for 
the activation of PI3K cascade downstream ligand-activated DmGiuRA (Lin et al., 
2011) (Fig.2.2). We found that the expression of a constitutively active 
CaMKIIT2870 transgene (Jin et al., 1998) is sufficient to activate P13K in the 
absence of glutamate and that CaMKII can suppress the hyperexcitability 
phenotype of DmG/uRA 112b. We also determined that DFak is required for this 
activation (Lin et al., 2011 ). A null mutation in DFak, DFa~G1 (Grabbe et al., 
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Figure 2.3: The activation of PI3K via DmGiuRA requires CaMKII and DFak. 
The glutamate-activation of DmGiuR most likely results in the ~roduction of 
intracellular Ca2+ intermediates, resulting in the activation of the Ca +/Calmodulin 
kinase, CaMKII. CaMKII subsequently activates Drosophila focal adhesion 
kinase (DFak) that then activates PI3K (Lin et al., 2011 ). Activation of PI3K 
regulates neural excitability via the modulation of the activity of dFOXO (Howlett 
et al. , 2008) 
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2004 ), blocks the ability of glutamate-activated DmGiuRA to initiate PI3K 
signaling and also prevents CaMKII from activating PI3K (Lin et al., 2011 ). Based 
on these results, we have concluded that the initiation of PI3K signaling by 
glutamate-activated DmGiuRA requires both CaMKII and DFak (Fig.2.2). 
2.1.4 The vertebrate Fak family member, Pyk2, can activate PI3K directly 
or via Ras: could Ras be a Dfak-PI3K signaling intermediate in the 
Drosophila motor neuron? 
The vertebrate nonreceptor tyrosine kinase, Fak, is involved in numerous 
cellular responses including cell adhesion, migration, differentiation, and cell 
survival (reviewed in Parsons, 2003). The closely related kinase, Pyk2, can be 
phosphorylated by CaMKII on multiple serines at the C-terminus which activates 
the phosphorylation of additional tyrosines (particularly Tyr402) by unknown 
mechanisms (Della Rocca et al., 1997; Zwick et al., 1999; Heidinger et al., 2002; 
Montiel et al., 2007). These phospho-tyrosines serve as binding sites for SH2 
domain containing proteins such as the p85 regulatory subunit of PI3K and the 
Ras activator, growth factor receptor-bound protein 2 (GRB2). In fact, Pyk2, has 
been shown to activate both Ras and PI3K (Chen and Guan, 1994; Guinebault et 
al., 1995; Montiel et al., 2007). Because DFak is the only member of the 
Pyk2/Fak family in Drosophila, it may perform the functions of both vertebrate 
Fak and Pyk2, which raises the question if DFak directly activates or indirectly 
activates PI3K through Ras. 
We suspect that Ras may be involved in PI3K activation in the motor nerve 
terminal because hyperactivated Ras confers several phenotypes that are 
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consistent with PI3K activation. As discussed in the Introduction, the 
overexpression of Ras in the Drosophila motor neuron increases synaptic 
outgrowth similar to what is observed with P13K overexpression (Koh et al., 2002; 
Martin-Pena et al., 2006; Howlett et al., 2008). Additionally, examination of a null 
mutation in the Ras-GAP protein NF1, revealed a decrease in motor neuron 
excitability similar to the effects of P/3K-CAAX (Eric Howlett, unpublished data). 
These observations indicate that in addition to CaMKII and DFak, that Ras may 
additionally be involved in the signaling cascade initiated by DmGiuRA activation. 
2.1.5 The activation of PI3K by DmGiuRA is Ras-dependent 
To address the activation of PI3K by DmGiuRA occurs in a Ras-independent 
or Ras-dependent manner we examined the levels of p-Akt in the motor neuron 
in a set of Ras transgenic lines, a Ras chromosomal loss-of-function mutant, and 
the PI3K variant, gen-P/3~80 that has a mutated Ras-binding domain before 
and after the application of glutamate. We additionally investigated the effect of 
inhibiting Ras activity on neural excitability. We found that the activation of PI3K 
by DmGiuRA signaling requires Ras. Reducing Ras activity and eliminating the 
ability of Ras to bind PI3K, as is the case for the gen-P/3K mutant, blocks the 
glutamate-stimulated increase of p-Akt in the motor neurons and increases motor 
neuron excitability, consistent with reduced PI3K activity. The discovery that the 
effect of PI3K on the regulation of motor neuron excitability is a Ras-dependent 
process provides additional insight into the PI3K-mediated control of specific 
processes involved in neural plasticity. 
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2.2 Materials and Methods 
2.2.1 Ga/4/UAS transgene expression system 
The GAL4/UAS transgene expression system is a robust methodology that 
allows for the temporal and spatial expression of genes in vivo in Drosophila 
(Brand and Perrimon, 1993). This system utilizes the specificity of the 
Saccharomyces cerevisiae transcription factor, Gal4, for the yeast promoter 
sequence upstream activating sequence ( UAS). By conjugating GAL4 to a 
specific promoter (either global or tissue-specific), Gal4 is effectively transcribed 
in the pattern of expression for that promoter. Gal4 specifically binds to and 
activates a UAS-conjugated transgene, thus expressing the UAS-conjugate in 
the pattern of the promoter expressing Gal4 (i.e., in muscle if the promoter is 
expressed in the muscle). This system allows for the expression of either reporter 
genes (such as green fluorescent protein, GFP) or modulatory transgenes (such 
as an RNA-interference transgene, RNAi) during development or in specific 
tissues of interest. Because GAL4 and UAS are not endogenous fly genes, 
expression of Gal4 does not perturb the function of genes other than the VAS-
conjugated transgenes. 
2.2.2 Fly stocks and husbandry 
All fly stocks were maintained on standard cornmeal/agar Drosophila media 
at 22°C in either half pint bottles or vials. General fly husbandry was carried out 
as described by Greenspan (1997). Experimental crosses/genotypes were kept 
in bottles and adult flies (10 male and 10 female) passaged to new bottles every 
four days to limit larval overcrowding. 
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Stocks: The principle GAL4 driver stock utilized for these experiments, D42-
GAL4, specifically expresses Gal4 in Drosophila motor neurons and was kindly 
provided to us by Tom Schwarz (Harvard Medical School, Boston, 
Massachusetts). To knockdown PI3K expression, we utilized a dominant-
negative UAS-Pt3K?N transgene that has an aspartic acid to alanine substitution 
at residue 954 (D945A; in the ATP-binding site of PI3K) that renders the 
molecule inactive. We additionally used the transgene UAS-PTEN, which drives 
expression of the PI3K inhibitor phosphatase and tensin homolog (PTEN), to 
decrease P13K activity. To increase PI3K activity, we utilized a constitutively-
active UAS-P/3K-CAAX transgene that contains a COOH-terminal isoprenylation 
signal that increases the hydrophobicity of the C-terminus. This C-terminal 
modification helps to target the molecule to the membrane where it can interact 
with its substrates (Klippel et al., 1996; Leevers et al., 1996). We acquired the 
Pt3K?N, P/3K-CAAX, and UAS-PTEN stocks from the Bloomington Drosophila 
stock center (Bloomington, IN). 
To modulate Ras activity in the motor neuron, we utilized a dominant-negative 
Ras transgene, UAS-Ra~17 that was provided to us by Denise Mantell (John 
Hopkins Medical School, Baltimore, MD). This variant has an asparagine residue 
substitution at position 17 (N17) (Lee et al., 1996) that sequesters the guanine 
nucleotide exchange factor (GEF) and thus prevents the activation of wildtype 
Ras (Powers et al., 1989). To additionally knockdown Ras activity, we also 
acquired and used a RNA interference transgene, UAS-RAS-RNAi, (National 
Institute of Genetics, Mishima, Japan) and heteroallelic mutant larvae, 
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Ras62F/Ras12A, which exhibit significantly lower levels of endogenous Ras 
(Zhong, 1995). Rase2F is a severe mutation that is homozygous lethal (Simon et 
al., 1991) and is kept as a balanced, heterozygous stock that was provided to us 
by Gerald Rubin (University of California, Berkeley, CA). Ras12A is a 
hypomorphic mutation that reduces normal levels of Ras (Zhong, 1995) and was 
provided to us by Celeste Berg (University of Washington, Seattle, WA). The 
Ras62F/Ras12A heteroallelic combination decreases Ras activity sufficiently to 
confer phenotypes but retains enough activity to maintain viability (Zhong et al., 
1995). For Ras-PI3K epitasis experiments, we recombined the Rai"17 and P/3K-
CAAX transgenes on to the same chromosome (Michael Stem) so they could be 
simultaneously expressed. 
Ras activates PI3K by binding directly to the catalytic subunit of PI3K (Orme 
et al., 2006; Rodriguez-Viciana et al, 1994; Pacold et al., 2000). The Leevers lab 
(London, UK) designed and constructed a Ras-binding domain (RBD) PI3K 
mutant (gen-P/3~80) by mutating four amino acids in the Ras-binding domain of 
the catalytic unit of PI3K (T231D, K250A, R253A, and K257A). This variant was 
produced as a genomic clone (so expression of this allele would be under the 
transcriptional control of the endogenous PI3K promoter) and was introduced into 
Drosophila as a transgene (Orme et al., 2006). A control line, gen-P/31<, with 
an unmodified Ras-binding domain, was similarly produced (Orme et al., 2006). 
Both of these stocks were provided to us by Sally Leevers (London Research 
Institute, London, UK). We crossed gen-P/31< and gen-P/3~80 into a P/31<" 
mutant allele background so that only the transgenic P/3~80 or P/31< are 
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expressed in mutant larvae. P/3KA was previously suggested to be a null allele of 
PI3K (Weinkove et al., 1999); however, we suspect that is in fact functioning like 
a dominant-negative for PI3K. P/3~ is predicted to encode a 668 amino acid 
protein truncated at the C-terminus, which may confer partial dominant-negative 
properties. 
2.2.3 Larval microdissection 
The larval neuromuscular junction (nmj) has proven to be a powerful model 
for the study of synaptic properties and function (Peron et al., 2009; Guo and 
Zhong, 2006; Wu et al., 2005; Bogdanik et al., 2004; Packard et al., 2003; 
Petersen et al., 1997; Schuster et al., 1991; Jan and Jan, 1978); therefore it is 
the principle Drosophila tissue utilized for this study. For dissections, wandering, 
third instar larvae were collected from the sides of half pint bottles within 48 
hours of their emergence. Larval dissections were performed as described by 
Jan and Jan (1978). In brief, an appropriately staged larva was placed into a 
dissection tray, and its head and tail pinned down with the dorsal side facing 
upwards using insect pins. The larva was then cut along the length of the dorsal 
midline, pinned open flat, and the guts and other major organs removed; 
however, the brain, ventral ganglion, and the peripheral nervous system were left 
intact (Fig.2.3). 
2.2.4 Larval anti-phosphorylated Akt (p-Aid) analysis 
Anti-p-Akt immunostaining: Akt is a downstream target of PI3K and is 
phosphorylated upon activation of PI3K, thus detection of phosphorylated-Akt 
can be used as a read-out of PI3K activity in the neuron (Dionne et al., 2006; 
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Figure 2.3: Overview of larval preparations used to analyze the Drosophila 
nmj. Larval dissections were performed using the standard protocol outlined by 
Jan and Jan (1978). (A} Diagram of a wandering, 3rd instar larva positioned 
dorsal side up. The larva has approximately 7 abdominal segments labeled from 
anterior to posterior as A2-A7, respectively. The most anterior segment, A1 , is 
further subdivided; however, this region was not the focus of this study therefore 
these segments are not labeled here. The dashed line represents the position of 
the dorsal midline where primary incision for dissection was made. (B) Diagram 
of the larval fillet prep with the body wall of the larva pinned open. The brain and 
peripheral nervous system (not shown) were left intact; however, the guts and 
other major organs were removed. The neurons innervating the longitudinal 
muscles 7 and 6 (M7 and M6), were the focus of this study. The positions of the 
motor neurons used for the p-Akt analysis are noted with stars. 
Colombani et al., 2005; Palomero et al., 2007; Howlett et al., 2008). To examine 
PI3K activity in the Drosophila nmj, wandering, third instar larvae were dissected 
in 1 x Schneider's Drosophila Medium (S2 media) (Invitrogen, Carlsbad, CA). This 
media is formulated to grow Drosophila S2 cells in culture and is better suited 
than standard 1x phosphate buffered saline (1xPBS;137 mM NaCI, 2.7 mM KCI, 
42 
4.3 mM Na2HP04, 1.47 mM KH2P04, pH 7.4) to keep dissected Drosophila 
tissues functionally active both during and (for a period of time) after dissection. 
To investigate basal levels of p-Akt (levels of p-Akt without glutamate 
application) the dissected larvae were immediately fixed in 4% paraformaldehyde 
for 15 minutes, then washed 3x in 1x PBS-T (1xPBS with 0.1% Triton-X 100). 
The preps were incubated overnight at 4°C with antibodies against Drosophila p-
Akt (monoclonal, directed against Ser505) raised in rabbit (Cell Signaling 
Technologies, Inc., Boston, MA) at a concentration of 1 :500. For visualization, 
the preps were incubated overnight at 4 oc with a Rhodamine Red-conjugated 
goat anti-rabbit antibody (Jackson lmmunoResearch, Westgrove, PA) at a 
concentration of 1:1000. The neurons were also simultaneously counter-stained 
with Cy2-conjugated anti-horse radish perioxidase (HRP) (Jackson 
lmmunoResearch) at a concentration of 1 :200. The anti-HRP antibody 
recognizes a carbohydrate on the surface of all Drosophila neurons, thus is a 
useful antibody for the visualization of neural structures in the fly (Jan and Jan, 
1982). 
Glutamate application: To investigate the activity of PI3K after the activation 
of DmGiuRA by glutamate, larvae were dissected as described above; however, 
prior to fixation, 100 IJM glutamate was added to the prep. To ensure that the 
glutamate would be applied evenly to the preps, 2 IJL of a prepared 1 0 mM 
glutamate solution (glutamic acid monosodium salt monohydrate; Acros 
Organics) was added to 198 IJL S2 media for a final concentration of 100 1JM 
glutamate. The media used for the dissection was replaced with the glutamate 
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solution and the prep was incubated with glutamate for 1 minute. After 
incubation, the dissection plate was immediately submersed in two baths of 
1 xPBS to remove the glutamate solution. Fixation and the visualization of p-Akt 
and neural immunostaining were performed as described above. 
Anti-p-Akt measurements: We used a Zeiss 510 laser scanning confocal 
microscope (LSM) collect images of a 1 0 1-1m thickness (corresponding to the 
depth of the neuron) using the 20X objective. Neurons between muscles 7 and 6 
spanning the length of the larva (i.g. from segments A3-A7) were imaged (Fig. 
2.3). To ensure that any observed changes in the anti-p-Akt staining intensity 
were due to transgenic manipulations affecting PI3K activity and not the result of 
image acquisition, the detector gain for the red channel (corresponding to the 
anti-p-Akt immunostaining) was set using the detector gain that established for 
the detection of the basal anti-p-Akt staining of the control preps. These same 
control gain settings were then used to acquire all of the subsequent neural 
images of the experimental preps. Because we observed day-to-day variation in 
anti-p-Akt fluorescent intensity, care was taken to always dissect an appropriate 
number of controls in parallel with the experimental larvae for every p-Akt 
experiment. 
To measure the intensity of the anti-p-Akt staining, each neuron was traced 
by hand with the NIH lmageJ (http://rsbweb.nih.gov/ij) freehand selection tool 
using the anti-HRP staining as a guide. The traced outline of the neuron was 
then superimposed on to the image that corresponded to the anti-p-Akt staining 
of the same neuron. The pixel intensity inside the traced region was measured 
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using the Image J measurement tool. Because the localization of the anti-p-Aid 
often did not completely fill in the traced outline of the neuron, a background 
subtraction was performed to minimize the effect of any background staining on 
the pixel intensity measurement. The background subtraction was performed by 
averaging the fluorescent intensity of a random area (excluding regions 
containing nuclei) from muscles 6 and 7 from the image taken in the red channel. 
The muscle average was subtracted from the intensity measured from each 
traced neuron. The anti-p-Akt staining intensity from multiple neurons ( -30 for 
each genotype) was measured and each of these individual measurements was 
normalized by dividing the measured intensity of each neuron by the overall 
average intensity of the basal p-Akt intensity of the controls. These normalized 
values were averaged for each data set and used to report the "average 
intensity'' of the basal and glutamate-applied anti-p-Akt staining. Standard error 
was calculated using the normalized intensity values for both the experimental 
and control groups and significance was calculated using a one-way ANOVA and 
Fisher's LSD. 
2.2.5 Electrophysiology 
To measure neuronal excitability, we measured the onset of a phenomenon 
termed "long term facilitation" (LTF) (Jan and Jan, 1978). L TF is a form of 
synaptic plasticity induced when a larval motor neuron is subjected to a train of 
repetitive nerve stimulations at low external Ca2+. Because Ca2+ is essential for 
neurotransmitter release to occur, the motor neuron initially responds to nerve 
stimulation at this low external Ca2+ with little neurotransmitter release, and thus 
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the muscle responds with depolarizations (termed excitatory junctional potential, 
or EJP) of a low amplitude. However, as repetitive stimulation continues, at a 
certain point during the stimulus train a threshold is reached and subsequent 
stimulations elicit EJPs of greatly increased amplitude, called L TF, resulting from 
a prolonged depolarization of the nerve terminal (Jan and Jan, 1978) (Fig.2.4). 
The number of stimulations required to reach this LTF threshold (LTF onset rate) 
is decreased by genetic conditions that increase neuronal excitability (Jan and 
Jan, 1978; Mallart et al., 1991; Poulain et al., 1994; Schweers et al., 2002; Stem 
and Ganetzky, 1989; Stern et al., 1990). 
Larvae were grown and selected as described above and dissected in Jan's 
buffer (128 mM NaCI, 2.0 mM KCI, 4.0 mM MgCI2, 34 mM sucrose, 4.8 mM 
HEPES, pH 7.1, and CaCI2 concentration as specified in the text). Peripheral 
nerves were cut immediately posterior to their exit from the ventral ganglion, and 
were stimulated with a suction 9 electrode at a 5V stimulus intensity. Muscle 
recordings were taken from muscle 6 in abdominal segments A3, A4 or A5 
(Fig.2.4). Stimulus duration, approximately 0.05 msec, was adjusted to 1.5 times 
threshold which reproducibly stimulates both axons innervating muscles 6 and 7. 
Intracellular recording electrodes for muscle potentials were pulled with a 
Flaming/Brown micropipette puller to a tip resistance of 1 Q-40 Mn and filled with 
3M KCI. Rate of onset of L TF were reported as geometric means because the 
data show a positive skew. For all L TF experiments, the bath solution contained 
0.15 mM Ca2+ and 100 !JM quinidine, which is a potassium channel blocker that 
sensitizes the motor neuron and enables L TF to occur and be measured even in 
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hypoexcitable neurons. The electrophysiology experiments for this project were 
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Figure 2.4: The larval motor neuron is useful for measuring neural 
excitability. (A) Larval fillet preps were used to access the motor neurons of a 
larval nmj. The neuron utilized for the electrophysiological recordings innervates 
muscles 7 and 6 (M? and M6) from abdominal segments A3-A6. Only one 
neuron was stimulated per larvae. (B) A suction electrode draws up and 
stimulates a single neuron at a 5V stimulus intensity. A recoding electrode 
positioned in M6 of the selected segment measures the electric potential. 
Stimulations result in depolarizations (termed excitatory junctional potentials, 
EJPs) in the target muscle. (C) To measure excitability, long-term facilitation 
(L TF) is induced by subjecting the neuron to a train of repetitive stimulations. 
These repetitive stimulations initially result in EJPs of a low amplitude. As 
stimulation continues, a threshold is reached where subsequent stimulations 
result in EJPs of greatly increased amplitude, called L TF. Genetic conditions that 
increase neuronal excitability decrease the number 9f stimulations required to 
reach this L TF threshold (considered hyperexcitable) and genetic conditions that 
decrease neuronal excitability increase the number of stimulations to reach this 
L TF threshold (hypoexcitable) (Jan and Jan, 1978; Mallart et al. , 1991; Poulain et 
al. , 1994; Schweers et al., 2002; Stern and Ganetzky, 1989; Stern et al., 1990). 
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2.3 Results 
2.3.1 Ras is required for glutamate-mediated activation of PI3K 
Our lab previously demonstrated that glutamate application to the Drosophila 
larval nmj activates PI3K via the single metabotropic glutamate receptor 
DmGiuRA (Howlett et al., 2008). PI3K is measured by monitoring levels of 
phosphorylated Akt (p-Akt) which increase with increasing PI3K activity (Dionne 
et al., 2006; Colombani et al., 2005; Palomero et al., 42007; Howlett et al., 2008). 
Increases in glutamate-evoked p-Akt are blocked in DmG/uRA 112b mutants or 
when DmGiuRA is knocked down by the motor neuron expression of DmG/uRA-
RNAi (Howlett et al., 2008). As shown in Figure 2.5, the application of glutamate 
to wildtype larvae induces a 30% increase in p-Akt levels (Fig. p=0.008). 
To determine if Ras is involved in the activation of PI3K, we inhibited the 
activity of Ras using the Ga/4/UAS system (Brand and Perrimon, 1993) to drive 
the expression of a dominant-negative Ras transgene (RaSJ17) and a Ras-RNAi 
transgene in the larval motor neuron and examined p-Akt activity using 
immunohistochemistry. We also examined p-Akt activity in the heterozygous 
chromosomal mutant Ras62F/Ras12A that decreases Ras activity sufficiently to 
confer phenotypes but retains enough activity to maintain viability (Zhong et al., 
1995). We found that RaSJ17, Ras-RNAi, and Ras62F/Ras12A did not alter the 
basal levels of p-Akt (the level of p-Akt present without the application of 
glutamate); however, these mutants blocked the ability of glutamate to activate 
P13K (Fig.2.5). These results indicate that Ras is a critical intermediate in the 
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Figure 2.5: Ras is required for glutamate-induced p-Akt increases in larval 
motor nerve terminals (A) Representative images of larval neuromuscular 
junctions of wildtype, D42>RasN17, D42>Ras-RNAi, Rase2F/Ras12A, gen-PI3K", 
and gen-P/3~80. Neurons were labeled with anti-p-Akt (red) either without or 
following a 1 minute application of 100 1JM glutamate. Preparations were also 
labeled with anti-HRP (green) to enable visualization of motor nerve terminals. 
White arrowheads indicate p-Akt immunoreactivity. Scale bar as indicated. (B) 
Means +/- SEMs of normalized pixel intensities (Y -axis) of the indicated 
genotypes (X-axis ). The pixel intensity of the anti-p-Akt staining was averaged 
for each genotype and normalized to the average intensity of the control 
preparation: values from Rase2F/Ras12A, gen-PI3K" and gen-P/3~80 were 
normalized to WT, whereas values from 042>RasN17 and 042>Ras-RNAi were 
normalized to 042>+ (data not shown). For all genotypes, n=30. One-way 
ANOVA and Fisher's LSD were used to find the following significant differences: 
WT vs. gen-P/31<", p<0.001; vs. gen-P/3~80, p<0.001. No significant differences 
in basal p-Akt were found for the following comparisons: 042>+ vs. 042>RasN17, 
p=0.936; vs. 042>Ras-RNAi, p=0.532; WT vs. Rase2F!Ras12A, p=0.81. 
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Ras has several effector pathways, including the Raf-ERK pathway, so to 
confirm that Ras inhibition was preventing increases in p-Akt by blocking PI3K 
activation, we examined the activation of p-Akt in a Ras-binding domain PI3K 
mutant, gen-P/3~80. This PI3K variant carries a four amino acid substitution in 
the Ras binding domain of PI3K that prevents activation by Ras but does not 
effect the activation of Ras by p85-dependent mechanisms (Pacold et al., 2000; 
Orme et al., 2006). We found that the application of glutamate to the gen-P/3/(" 
expressing larvae resulted in a significant increase in the levels of p-Akt (Fig). 
This increase in p-Akt was not observed after glutamate was applied to the gen-
P/3~80 larvae (Fig.2.5). These results confirm that Ras is a critical intermediate 
for the glutamate-activation of P13K. 
We also observed that the basal levels of p-Akt were decreased in the gen-
P/3/(" larvae (Fig.2.5). These larvae only carry one copy of the gen-P/3/(" 
transgene and both copies of the endogenous P/3K have been replaced with the 
allele P/3KA; therefore the basal decrease in p-Akt levels are most likely a 
consequence of decreased PI3K gene dosage. Likewise, the basal levels of p-
Akt in the gen-P/3~80 larvae are lower than both wildtype and gen-P/3/(". 
These larvae only have a single copy of the gen-P/3~80 transgene that is only 
responsive to p85-dependent activation which further limits PI3K activity. To 
further assess the effect of gene dosage on the levels of p-Akt, we compared the 
basal levels of wildtype p-Akt to the levels of gen-P/3/(" and P/3KA crossed to 
wildtype. If the levels of p-Akt are sensitive to the amount of gene expression, we 
would expect to that the gen-P/3/("f+ heterozygotes would have wildtype levels of 
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basal p-Akt and the P/3/('/+ heterozygotes would have half as much p-Akt 
staining. As expected, the P/3KA/+ heterozygotes had reduced p-Akt levels 
compared to wildtype (Fig.2.6). Interestingly, the gen-P/3/('/+ heterozygotes 
additionally exhibited reduced p-Akt levels (Fig.2.6). We believe that this because 
P/3/(' is functioning like a dominant-negative rather than a null like previously 
reported (Weinkove et al., 1999). P/3/(' is predicted to encode a 668 AA protein 
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Figure 2.6: p-Akt in the motor neuron is affected by PI3K gene dosage. 
Means+/- SEMs of normalized pixel intensities (Y-axis) of the indicated 
genotypes (X-axis). The pixel intensity of the anti-p-Akt staining was averaged 
for each genotype and normalized to the average intensity of the wildtype 
preparation. For all genotypes, n=30. One-way ANOVA and Fisher's LSD were 
used to find the following significant differences: WT vs. PI3K+/+, p=0.029; vs. 
gen-P/3/(', P/3KA /+, p<0.0005. No significant difference was found between 
P/3/('f+ vs gen-P/3/(', P/3/('J+, p=0.183. 
We have recently reported that CamKII and DFak are critical intermediates Of 
DmGiuRA-mediated PI3K signaling (Lin et al., 2011 ). Interestingly, we found that 
the inhibition of CaMKII and DFak in the motor neuron results in a decrease in 
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the basal levels of p-Akt, indicating that CamKII and DFak are regulating PI3K 
signaling even when DmGiuRA is not activated (Lin et al., 2011 ). Inhibiting the 
activity of Ras does not similarly alter the basal levels of p-Akt (Fig.2.5), 
indicating that Ras is primarily engaged in the activation of PI3K in the motor 
neuron when DmGiuRA is activated by glutamate. 
2.3.2 The effect of PI3K on motor neuron hyperexcitability is Ras-
dependent 
We have previously demonstrated that increasing and decreasing PI3K 
activity increases and decreases neural excitability, respectively (Howlett et al., 
2008). DmG/uRA 112b exhibits increased motor neuron excitability (Bogdanik et al., 
2004) and our lab has determined that this effect is the result of aberrant PI3K 
signaling. To explore the possibility that Ras is additionally involved in the 
regulation of excitably via DmGiuRA-mediated PI3K signaling, we examined the 
neural excitability in a series of transgenic and chromosomal mutants that inhibit 
the activity of Ras. If Ras is required for this process, we would expect that 
inhibiting Ras would increase neural activity similar to what is observed when 
PI3K activity is decreased (Howlett et al., 2008). 
To measure excitability, we used the rate of onset of a phenomenon called 
"long term facilitation" (LTF) (Jan and Jan, 1978). LTF is a form of synaptic 
plasticity induced when a larval motor neuron is subjected to a train of repetitive 
nerve stimulations at low external Ca2+ (for a more detailed explanation, see 
Methods section above). At low Ca2+, a repetitive stimulation eventually results in 
high amplitude depolarizations, termed excitatory junctional potentials (EJPs) 
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that are the result of asynchronous neurotransmitter release. The number of 
simulations required to reach this L TF threshold can be increased or decreased 
by changes in gene expression that alter neuronal excitability (Schweers et al., 
2002; Poulain et al., 1994; Mallart et al., 1991; Stem et al., 1990; Stem and 
Ganetzky, 1989; Jan and Jan, 1978). 
We measured the onset of L TF (the number of stimulations required to reach 
asynchronous neurotransmitter release) in larvae expressing the dominant-
negative RasN17 as well as the heterozygous chromosomal mutant, 
Rase2F!Ras12A. We observed that both genotypes significantly increased the LTF 
onset rate (Fig.2. 7), similar to what we observed when PI3K activity is inhibited. 
To confirm that Ras increases excitability by preventing PI3K activation, we also 
examined L TF onset rate in the PI3K variants, gen-PI3K'" and gen-P/3~80. We 
observed that gen-RBD has a L TF onset rate that was significantly greater than 
the gen-PI3K'" or controls (Fig.2. 7), indicating that gen-P/3~80 is hyperexcitable 
(Fig.2. 7), suggesting that the capacity of PI3K to decrease neural activity 
requires Ras. This conclusion is consistent with the previous experiments 
suggesting that ligand-activated DmGiuRA requires PI3K activity to decrease 
motor neuron excitability (Howlett et al., 2008) and that the ability of DmGiuRA to 
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Figure 2. 7: Preventing Ras-dependent PI3K activation increases neuronal 
excitability. The larval neuromuscular preparation (Jan and Jan, 1976) was 
used for all recordings. (A) Representative traces showing increased rate of 
onset of LTF in 042>+, D42>RasN17, gen-P/31<!, and gen-P/3~80 in motor 
neurons. Arrowheads indicate the increased and asynchronous EJPs, indicative 
of onset of L TF. The bath solution contained 0.15 mM [Ca2+] and 100 JJM 
quinidine. Nerves were stimulated at a frequency of 10 Hz for each trace. (B) 
(Left panel) Geometric means +/- SEMs of the number of stimulations required to 
evoke LTF (Y-axis) at the indicated stimulus frequencies (X-axis) for the following 
genotypes: 042>+, 042>RasN17, Rase2F/Ras12A. From left to right, n = 12, 13, 6. 
(Right panel) Geometric means +/- SEMs of the number of stimulations required 
to evoke L TF (Y-axis) at the indicated stimulus frequencies (X-axis) for the 
following genotypes: 042>+, gen-P/31<!, gen-P/3~80. From left to right, n= 12, 6, 
7. One-way ANOVA and Fisher's LSD gave the following differences at 3 Hz, 5 
Hz, 7 Hz, and 10 Hz, re~ectively: For 042>+ vs. 042>RasN17, p=0.02, 0.002, 
0.0008, 0.006; vs. Rase2 /Ras12A, p=0.06, 0.005, 0.006, 0.016; vs. gen-P/31<!, 
p=0.902, 0.355, 0.449, 0.827; vs. gen-P/3~80, p=0.403, 0.29, 0.006, 0.002. For 
gen-P/31<! vs. gen-P/3~80, p=0.612, 0.245, 0.037, 0.002. 
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2.4 Discussion 
2.4.1 DmGiuRA-mediated activation of PI3K requires Ras 
Our lab has previously shown that the ligand-activation of DmGiuRA initiates 
a PI3K-mediated signaling cascade that negatively regulates neural excitability 
(Howlett et al., 2008). This study has found that Ras, an important modulator of 
cellular activity, is also an integral part of this signaling network. Inhibition of Ras 
via transgene expression and chromosomal loss-of-function blocks the ability of 
DmGiuRA to activate the PI3K signaling cascade (Fig.2.5). Diminished PI3K 
signaling results in loss of negative feedback control and an abnormal increase in 
neural excitability (Fig.2. 7) which we have previously shown is mediated by the 
inhibition of FOXO activity by P13K-Akt signaling (Howlett et al., 2008). 
Furthermore, the observation that the Ras-insensitive PI3K variant, gen-P/3~80, 
is hyperexcitable (Fig.2. 7) additionally demonstrates the critical role of Ras in 
these feedback processes. 
To our knowledge, a requirement for Ras during mGiuR-mediated signaling 
has not been previously demonstrated. The activities of Ras and PI3K are known 
to modulate neural function, including L TP and LTD (reviewed in Ye and Carrow, 
201 0); however, a clear delineation between the Ras-dependent and Ras-
independent PI3K-mediated mechanisms has not been established. This study 
indicates that Ras is required for the effects of PI3K on the modulation of neural 
function. It was previously shown that LTD can be reliably induced in the 
synapses of the Drosophila nmj and that Akt chromosomal mutants exhibit 
significant impairments in motor neuron LTD (Guo and Zhong, 2006). In 
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vertebrate systems, the PI3K-Akt-mTOR cascade is required for the initiation of 
group I mGiuR-LTD (Hou and Klann, 2004) and though the group II mGiuRs, of 
which DmGiuRA is the most similar, have also been demonstrated to elicit L TO, it 
is currently unknown if there is a similar requirement for this pathway. We have 
previously established a role for DmGiuRA-PI3K signaling in the regulation of 
neural excitability (Howlett et al., 2008) and the results of this study have now 
identified Ras as another key intermediate in the DmGiuRA pathway mediating 
excitability. Downregulating excitability may be a key process in the 
establishment of L TO; therefore, these results indicate that Ras and PI3K may 
participate in LTD regulation in the Drosophila motor neuron. Because altered 
LTD is implicated in autism (reviewed in Bear et al., 2004) and altered group II 
mGiuR expression is associated with (Gupta et al., 2005; Aronica et al., 1997; 
Pacheco et al., 2006), it may be of merit to investigate if this pathway is 
conserved in vertebrates. 
2.4.2 Proposed model for the role of Ras in DmGiuR-PI3K mediated 
negative feedback regulation 
Based on several lines of evidence, our lab has proposed a model by which 
glutamate-activated DmGiuRA engages PI3K in a negative feedback signal that 
downregulates neural excitability (Howlett et al., 2008). In this model, glutamate 
released from the motor nerve terminal as a consequence of neural activity, 
feeds back on DmGiuRA located on the same nerve terminal. Glutamate binding 
to DmGiuRA activates PI3K signaling which downregulates neural excitability via 
the inhibition of dFOXO (Fig.2.1) (Howlett et al., 2008). 
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We have previously shown that the activation of DmGiuRA by glutamate 
increases levels of intracellular Ca2+ (Eric Howlett, unpublished data). We 
proposed that ligand-bound DmGiuRA activates a phospholipase C (PLC) and 
inositol 1 ,4,5 trisphosphate receptor (IP3R)-dependent Ca2+ transient that 
activates a signaling cascade via the Ca2+ /Calmodulin kinase CaMKII. 
Consistent with this hypothesis, we have recently demonstrated that CaMKII and 
DFak are critical signaling intermediates linking DmGiuRA to PI3K activation 
(Fig) (Lin et al., 2011 ). This current study has now identified Ras as another 
important molecule essential for the activation of PI3K during DmGiuRA-
mediated intracellular signaling. 
Because DFak is the only Fak/Pyk2 nontyrosine tyrosine kinase family 
member in Drosophila, it may perform the functions of both molecules. Pyk2 has 
been shown to activate Ras and PI3K (Chen and Guan, 1994; Chen et al., 1996; 
Guinebault et al., 1995; Montiel et al., 2007), therefore DFak may be activating 
PI3K indirectly via Ras during DmGiuRA-initiated signaling (Fig.2.8). In this 
scenario, DmGiuRA-mediated CamKII-DFak-Ras signaling would activate PI3K 
via the Ras-binding domain. Alternatively, activated DmGiuRA may initiate two 
separate, parallel pathways, one involving CaMKII-DFak and the other involving 
Ras that converge on PI3K (Fig.2.8). In this second situation, Ras would activate 
PI3K via the Ras-binding domain and DFak would activate PI3K in a pBS-
dependent manner leading to the "full" activation of PI3K during DmGiuRA-
mediated signaling. 
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Figure 2.8: DmGiuRA may activate Ras via DFak or through DFak-
independent mechanisms. Ras is a critical signaling intermediate facilitating the 
initiation of PI3K in response to DmGiuRA activation. (A) In response to 
DmGiuRA activation, DFak may activate Ras, which then directly interacts with 
and activates PI3K via the Ras-binding domain of PI3K. This mechanism may be 
the exclusive activation step, or in concert with Ras, DFak may also interact and 
activate PI3K through the p60 subunit. (B) Activation of DmGiuRA may initiate 
the CaMKII-DFak as well as a separate Ras-mediated pathway for the "full" 
activation of PI3K in response to a glutamate signal. 
There are several potential mechanisms by which Ras may be activated by 
DmGiuRA. Disassociated Gai and GJ3y-subunits of activated G proteins have 
been shown to modulate Ras in many different cell types (reviewed in Goldsmith 
and Dhanasekaran, 2007). DmGiuRA has been shown to couple to G/G0 
(Parmentier et al., 1996) and could potentially activate Ras via the disassociated 
a- or J3y-subunit. Additionally, increases in intracellular Ca2+ (from cellular influx 
or release of Ca2+ from intracellular stores) have been found to activate Ras 
(reviewed in Agell et al., 2002). In vertebrates, two neural specific Ras guanine 
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exchange factors (Ras-GEFs), Ras guanyl nucleotide-releasing protein (Ras-
GRP) and Ras-guanine-nucleotide-releasing-factor (Ras-GRF), activate Ras in a 
Ca2+ dependent manner. Ras-GRP, coupled with diacylglyercol (DAG), activates 
Ras in neural cells (Ebinu et al., 1998). The second neural specific Ras-GEF 
molecule, Ras-GRF, activates Ras in a Ca2+ -calmodulin specific manner 
(Farnsworth et al., 1995). In neurons, CaMKII can additionally negatively regulate 
the Ras-inhibitor, synaptic GTPase-activating protein (SynGAP), via 
phosphorylation (Chen et al., 1998). These Ras-GEFs and SynGAP are known 
to participate in the modulation of LTP and structural plasticity (Vazquez et al., 
2004; Ye et al., 2000; Kim et al., 1998) and therefore may be additional 
participants worth investigating in relation to mGiuR-mediated signaling. We 
previously found that ligand-activated DmGiuRA increases intracellular Ca2+ (Eric 
Howlett, unpublished data) and an ortholog of the vertebrate Ras-GRP (Son of 
sevenless; Sos) has been identified in Drosophila (Rogge et al., 1991). 
Additional experiments will need to be performed to determine if the DmGiuRA-
activation of Ras involves Ca2+ -related mechanisms in the motor neuron. 




3.1.1 Abnormal synaptic growth has been observed in several 
neurological disorders 
Alterations in synaptic structure and morphology have been identified in 
several neurological disorders hallmarked by ASD, including Fragile X Syndrome 
(Kaufmann and Moser, 2000; Restivo et al., 2005). As previously discussed, 
PI3K signaling is involved in the processes that modify synaptic strength 
(Sharma et al., 2010; Gladding, 2009; Bourgeois, 2009; Hou and Klann, 2004; 
Man et al., 2003), axon guidance and growth during development (Akiyama and 
Kamiguchi, 2010; Vodrazka et al., 2009; Brandt et al., 2007; Jossin and Goffinet, 
2007; Markus et al., 2002) as well as the regulation of the morphology and 
complexity of dendritic spines (Kumar et al., 2005; Jaworski et al., 2005). The 
fact that aberrant PI3K signaling has been identified in several neurological 
disorders that have co-morbidity for autistic traits, including FXS and tuberous 
sclerosis, illustrates the significant role that signaling pathways that link fonn and 
function play in the refinement of cognitive function. Investigating the initialization 
and regulation of the PI3K pathway components may elucidate novel strategies 
for the treatment of these disorders. 
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3.1.2 PI3K and Ras participate in neural growth processes 
Current evidence points towards mTORIS6K as the primary PI3K effector 
pathway mediating the growth effects of PI3K in the nervous system (Vodrazka 
et al., 2009; Howlett et al., 2008; Jossin and Goffinet, 2007; Kumar et al., 2005); 
however, the molecules facilitating the activation of PI3K in a majority of these 
processes have not been identified. The GTPase Ras has been recognized an 
important activator of PI3K (Orme et al., 2006; Rodriguez-Viciana et al., 1994). 
Ras binds to a specific Ras-binding domain (RBD) of the catalytic unit of PI3K, 
inducing a conformation change that activates the kinase activity of PI3K 
(Rodriguez-Viciana et al., 1996). The overexpression of Ras has been shown to 
increase dendrite size and complexity in transgenic mice (Arendt et al., 2004; 
Gartner et al., 2004; Alpar et al., 2004), similar to what has been observed when 
PI3K or components of the PI3K pathway are hyperactivated (Kumar et al., 2006; 
Jaworski et al., 2005; Markus et al., 2002), suggesting that Ras may participate 
in the activation of PI3K during P13K-related neural outgrowth processes. 
However, the activation of the MAP kinase ERK via Ras has also been shown to 
modify neural outgrowth (Ye and Carew, 201 0; Kumar et al., 2005; Jaworski et 
al., 2005; Arendt et al., 2004; Koh et al., 2002), therefore it is unclear if the 
growth phenotypes associated with Ras activity are due to the activation of one 
or perhaps both of these effector pathways. 
The ERK and PI3K cascades have in fact been shown to function 
cooperatively in the outgrowth of axons and dendrites in cultured neurons, 
though each pathway appears to have a differential effect on growth (Kumar et 
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al., 2005; Jaworski et al., 2005; Markus et al., 2002). Both the ERK and PI3K 
cascades are required for outgrowth in cultured sensory neurons; however, ERK 
signaling is necessary for axon elongation whereas PI3K activation additionally 
modifies axon diameter and branching (Markus et al., 2002). Similarly, both the 
ERK and PI3K pathways act in concert to regulate dendrite formation in cultured 
hippocampal neurons, but PI3K activation also modifies dendrite size (Kumar et 
al., 2005; Jaworski et al., 2005). In both of these studies, the authors utilized 
pharmacological inhibitors of the ERK and PI3K cascades that target effectors 
downstream Ras (in the case of ERK, the pharmacological inhibitor U0126 
inhibits the activity of MEK and in the case of PI3K, L Y294002 competitively 
binds to and inactivates the P13K ATP-binding site), therefore these studies did 
not specifically address if Ras is required for the effects of PI3K on dendrite 
growth. 
Similar to vertebrates, the manipulation of the ERK and PI3K signaling 
pathways has also been found to alter synaptic outgrowth in Drosophila. Several 
studies have demonstrated that modulating PI3K activity in the motor neuron 
alters motor neuron arborization (Howlett et al., 2008; Martin-Peiia et al., 2006). 
Our lab additionally found that PI3K activity modifies the diameter of the 
peripheral nerve axons (Howlett et al., 2008). Ras has additionally been reported 
to regulate motor neuron synaptic outgrowth through the Ras-ERK pathway (Koh 
et al., 2002). The activation of ERK was suggested to promote bouton formation 
by phosphorylating and thus downregulating the cell adhesion molecule Fasciclin 
II (Fasll) (Koh et al., 2002; Koh et al., 1999). Fasll, the Drosophila ortholog of the 
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vertebrate neural cell adhesion molecule (NCAM), forms a stabilization complex 
with Discs-Large (DLG) that must be removed to allow synaptic outgrowth to 
occur (Thomas et al., 1997; Davis et al., 1997; Zito et al., 1997; Tejedor et al., 
1997). 
3.1.3 The PI3K-mediated effects on synaptic growth are Ras-
independent 
Because the Drosophila larva provides a tractable system for the study of 
synaptic architecture, we decided to further explore a requirement for Ras during 
PI3K-mediated synaptic growth. To explore if the PI3K affects on neural growth 
are Ras-dependent or Ras-independent processes, we examined the effect of 
inhibiting Ras activity on arborization to determine if altering Ras activity could 
phenocopied the growth defects observed when PI3K activity is inhibited (Howlett 
et al., 2008; Martin-Pena et al., 2006). We additionally assayed the growth 
phenotypes associated with a Ras-insensitive PI3K mutant, gen-P/3~80. We 
found that similar to reducing PI3K activity, knocking down Ras in the motor 
neuron diminishes arborization; however, the expression of a constitutively-active 
PI3K transgene did not completely block the Ras phenotype, suggesting that Ras 
is not epistatic to PI3K. Subsequent analysis of gen-P/3~80 additionally 
revealed no arborization defect, indicating that Ras and PI3K modulate 
arborization via separable pathways and that the effect of PI3K on synaptic 
growth is Ras-independent. 
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3.2 Materials and Methods 
3.2.1 General fly husbandry and stocks 
Husbandry: All fly stocks were maintained on standard commeaVagar 
Drosophila media at 22°C in either half pint bottles or vials (Genesse Scientific, 
San Diego, CA). General fly husbandry was carried out as described by 
Greenspan (1997). Experimental crosses/genotypes were kept in bottles and 
adult flies (10 male and 10 female) passaged to new bottles every four days to 
limit the overcrowding of offspring. 
Stocks: The stocks utilized for these experiments were previously described 
in Chapter 2. In addition to these stocks, we also utilized the dominant-negative 
Raf transgenic stock, UAS-RafN. This variant has a lysine to methionine 
substitution at position 497 (K497M) that renders the protein "kinase-dead" 
(Radke et al., 2001 ). For epitasis experiments, we also produced a UAS-RafN, 
UAS-P/3K-CAAX double-mutant stock (Michael Stem). 
3.2.2 Arborization analysis 
To visualize the motor neurons innervating the Drosophila nmj, wandering, 
third instar larvae were collected and dissected as described in the Materials and 
Methods section of Chapter 2. Larvae were dissected in 1xPBS (137 mM NaCI, 
2.7 mM KCI, 4.3 mM Na2HP04, 1.47 mM KH2P04, pH 7.4). These larval preps 
were fixed in 4% paraformaldehyde for 15 minutes then washed 3x for 10 
minutes in 1xPBS-T (1xPBS with 0.1% Triton-X 100). The larval preps were 
incubated overnight at 4°C with Cy2-conjugated antibodies against horseradish 
peroxidase (HRP) raised in goat (anti-HRP, Jackson lmmunoResearch) at a 
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concentration of 1 :200. The larvae were mounted onto slides in 50o/o glycerol-
1 xPBS solution and visualized with a Zeiss 510 laser scanning confocal 
microscope (LSM) using the 20x objective. For the arborization analysis, the nmj 
of larval abdominal segments 3 and 4 (A3 and A4, respectively) between 
muscles 7 and 6 (Fig.3.1) were imaged. To quantify arborization, the total 
numbers of boutons (which are round protrusions extending from the axons that 
constitute the pre-synaptic region of a synapse) were counted for each of the 
A 
Motor neurons { 
innervating 





region of counted 
boutons 
Figure 3.1 Location of motor neurons used for arborization analysis. Larval 
dissections were performed using the standard protocol outlined by Jan and Jan 
(1978). (A) Diagram of a fillet prep of a wandering, 3rd instar larva positioned 
dorsal side up. The motor neurons innervating muscles 7 and 6 (M7 and M6) of 
abdominal segments 3 and 4 (A3 and A4) were used for analysis. The locations 
of the neurons are denoted with stars. (B) Image of the neuron innervating M7 
and M6. Neurons were visualized by immunostaining with an anti-HRP antibody. 
The insert shows an enlarged region of the neuron outlined with a white square. 
The circles and arrows indicate representative boutons that would have been 
counted as part of the arborization analysis 
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neurons in the areas defined above. The cell counter application in lmageJ was 
utilized to count the boutons from each image and an average number was 
calculated for each genotype. A standard error of the mean (SEM) was 
calculated for each genotype and an ANOVA and a Fisher's LSD used to 
evaluate significance. 
3.3 Results 
3.3.1 The effect of PI3K on synaptic growth is Ras-independent 
The activity of Ras and PI3K have been shown to modify synaptic outgrowth 
(Akiyama and Kamiguchi, 2010; Ye and Carew, 2010; Howlett et al., 2008; 
Martin-Pena et al., 2006; Kumar et al., 2005; Jarwoski et al., 2005; Arendt et al., 
2004; Koh et al., 2002). In Drosophila, the overexpression of Ras in the motor 
neuron was shown to significantly increase synaptic growth at the nmj (Koh et al., 
2002). Similarly, the overexpression and inhibition of PI3K in the Drosophila 
motor neuron was demonstrated to increase and decrease synaptic growth, 
respectively (Howlett et al., 2008; Martin-Pena et al., 2006). Because Ras can 
activate PI3K (Rodriguez-Viciana et al., 1994; Orrne et al., 2006), we wanted to 
investigate what PI3K-regulated growth processes may be Ras-dependent or 
Ras-independent in Drosophila motor neurons. To test if Ras and PI3K are 
functioning in the same pathway, we performed a series of experiments that 
altered the activity of Ras and PI3K via transgene expression in the motor 
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Figure 3.2: Ras activity promotes synaptic bouton formation. (A) 
Representative confocal images of neuromuscular junctions from larvae of the 
indicated genotypes labeled with an antibody against HRP. Motor neurons 
innervating muscles 6 and 7 from segments A3 or A4 are shown. Scale bar 20 
IJm. (B) Mean number+/- SEM of synaptic boutons (Y-axis) from neuromuscular 
junctions of the indicated genotypes (X-axis ). Number of neuromuscular junctions 
analyzed: for WT, n=12; for 042>+, n=20; for D42>PTEN, n=17; for 
D42>RasN17, n=31; for D42>Ras-RNAi, n=11; for Rase2F/Ras12A, n=27. 
Significant differences in bouton number among genotypes (from one way 
AN OVA and Fisher's LSD or Student's t test, as appropriate) are indicated on the 
figure. 
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inhibitor, PTEN, significantly decreased arborization (Fig.3.2) whereas 
expression of a constitutively active PI3K transgene (P/3K-CAAX) increased 
arborization (Fig.3.3) as measured by the average total number of synaptic 
boutons. Similar to inhibiting PI3K, we found that the expression of a dominant-
negative Ras transgene (Ras"'17) or a Ras RNA interference transgene (Ras-
RNAI) significantly reduced motor neuron axon arborization (Fig.3.2). Synaptic 
outgrowth was also reduced in the Ras heteroalleic hypomorphic mutant, 
Ras82F/Ras12A in which Ras activity is reduced in all tissues (Fig.3.2). These 
results indicate that Ras is required for synaptic outgrowth; however, it is unclear 
whether the effects of Ras are due to the inhibition of the Ras-ERK or the Ras-
PI3K cascade. To address if PI3K is epistatic to Ras, we co-expressed 
constitutively-active P/3K-CAAX transgene with Ras"'17 to determine if PI3K could 
block the Ras"'17 growth defect. We found that expression of the constitutively 
active PI3K did in fact increase arborization compared to Ras"'17; however it did 
not completely block the Ras"'17 arborization defect (Fig.3.3). This result suggests 
that Ras and PI3K may be affecting outgrowth via parallel pathways. 
To further investigate a requirement for Ras, we additionally examined 
outgrowth in the Ras-insensitive PI3K variant, gen-P/3~80, which has a four 
amino acid substitution in the Ras binding domain that prevents Ras from binding 
to and activating PI3K (Orme et al., 2006; Pacold et al., 2000). We expected that 
if Ras was required for the effect of PI3K on growth that arborization would be 
reduced in this mutant. We observed no significant difference in motor neuron 
arborization in the P/3~80 variant compared to either the gen-P/31<" control or to 
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wildtype larvae (Fig.3.3). These results suggest that the effect of PI3K on axon 
arborization is Ras-independent. 
3.3.2 Ras-ERK signaling is required for the synaptic outgrowth of the 
Drosophila motor neuron 
Ras was previously shown to modify synaptic growth via the Ras-ERK-Fasll 
in the Drosophila motor neuron (Koh et al., 2002). In vertebrate hippocampal 
neurons, both the Ras-ERK and PI3K pathways function cooperatively to 
regulate dendrite growth (Kumar et al., 2005; Jarwoksi et al., 2005). To 
investigate the possibility that Ras-ERK and PI3K are functioning in parallel, we 
additionally inhibited the activity of Raf, the principle Ras effector that mediates 
the Ras-ERK cascade, by expressing a dominant-negative Raf transgene 
(RafN). Similar to inhibiting Ras and PI3K, expressing RafN in the motor neuron 
significantly reduced axon arborization (Fig.3.3). To investigate if P13K could 
promote synaptic growth in the absence of Ras-Raf-ERK activation, we co-
expressed P/3K-CAAX with RafN. We found that P/3K-CAAX could not block 
the RafN arborization defect, indicating that the activity of PI3K is not sufficient to 
orchestrate synaptic outgrowth in the absence of Raf-ERK signaling. This data 
indicates that the Ras-ERK and PI3K pathways cooperate synergistically to 
facilitate synaptic outgrowth. Presumably, the quantitatively different outcomes 
on synaptic outgrowth conferred by RaS'17 and RafN reflect differences in 
transgene expression which is an observation that is consistent in previous 
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Figure 3.3: Ras regulates synaptic bouton number via Raf, not PI3K. 
(A} Representative images of larval neuromuscular junctions of wildtype (WT), 
D42>RafN, gen-P/31<" gen-P/3~80, D42>RafN, P/3K-CAAX, D42>P/3K-CAAX. 
Neurons were labeled with anti-HRP. Scale bar 20 IJm. (B) Mean number+/-
SEM of synaptic boutons (Y -axis) from neuromuscular Lunctions of the indicated 
genotypes (X-axis): WT, 042>+, gen-P/31<", gen-PJ3K!'<80, D42>P/3K-CAAX, 
D42>RafN, P/3K-CAAX, D42>RasN17, P/3K-CAAX. From left to right, n =12, 20, 
10, 9, 26, 6, 28, 21. Significant differences in bouton number among genotypes 
(from one way AN OVA and Fisher's LSD or Student's t test, as appropriate) are 
indicated on the figure. 
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3.4 Discussion 
3.4.1. The effect of PI3K on neural growth is Ras-independent 
Previous reports by our lab and others have demonstrated that the activity of 
Ras and PI3K can alter Drosophila neural outgrowth (Howlett et al., 2008; Lavery 
et al., 2007; Martin-Pena, 2006; Koh et al., 2002). In this study we have found 
that the effect of PI3K on synaptic growth is Ras-independent. We found PI3K 
activity could not block the decrease in synaptic growth that occurred when Ras 
was inhibited in the motor neuron (Fig.3.3). This observation is consistent with a 
previous report that found that the expression of a constitutively-active Ras 
transgene that only activates the PI3K effector pathway (Rasv12C4~ failed to 
increase synaptic bouton number (Koh et al., 2002). We further demonstrated 
that the PI3K Ras-binding domain variant, gen-P/3~80, did not exhibit a growth 
defect (Fig.3.3). These results indicate that Ras is not required for the effect of 
PI3K on synaptic growth. 
3.4.2 CaMKII and Insulin growth factors may activate PI3K to mediate 
synaptic outgrowth 
Subsequent signals activating PI3K to promote arborization are unknown; 
however, recent work by our lab suggests that the Ca2•/calmodulin-dependent 
protein kinase II (CaMKII) may act upstream PI3K to mediate arborization. We 
and others have demonstrated that CaMKII is both necessary and sufficient to 
promote motor neuron arborization (Lin et al., 2011; Beumer et al., 2002; Koh et 
al., 1999). We found that the expression of the CaMKII inhibitory peptide a/a2 
decreases synaptic bouton number and that this decrease can be suppressed by 
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the expression of P/3K-CAAX, suggesting that CaMKII inhibition blocks 
arborization by preventing PI3K activation (Lin et al., 2011 ). 
Alternatively, insulin growth factors may also function as potential PI3K 
activators during synaptic growth. The insulin receptor (INSR)-PI3K pathway is 
an important regulator of cell metabolism and it has been increasingly recognized 
that neuronal circuits are targets for insulin (Barsh and Schwartz, 2002; Konner 
et al., 2009). Insulin-like and Insulin Receptor-like immunoreactivity are present 
at the Drosophila larval nmj (Budnik et al., 1990) and both insulin and insulin 
growth factors are capable of activating PI3K in a Ras-independent manner 
(Backer et al., 1992). 
3.4.3 The effect of PI3K on synaptic outgrowth requires ERK signaling 
Similar to previous observations made in vertebrate systems, our data 
supports the notion that the Ras-ERK and PI3K pathways function in parallel to 
alter neural outgrowth (Kumar et al., 2005; Jaworski et al., 2005; Markus et al., 
2002). Kumar et al., (2005) demonstrated that the application of either the PI3K 
pharmacological inhibitor L Y294002 or the MEK inhibitor U0126 blocked the 
effect of constitutively active Ras on dendrite outgrowth, indicating that both 
pathways in concert were required to facilitate growth. We found that expression 
of P/3K-CAAX only partially suppressed the growth defect of Ra~17 and did not 
suppress the effect of RafN on axon growth (Fig.3.3), suggesting that ERK 
signaling is required in concert for the effect of PI3K on synaptic outgrowth in the 
Drosophila motor neuron. 
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The Ras-ERK pathway was previously shown to participate in synapse 
formation in Drosophila via the modulation of the Discs-Large - Fascilin II (DLG-
Fasll) cell adhesion complex (Koh et al., 2002). Fasll, the ortholog of the 
vertebrate neural cell adhesion molecule (NCAM) (Schuster et al., 1996), 
regulates presynaptic morphology and growth cone targeting (Thomas et al., 
1997; Davis et al., 1997). DLG associates with synaptic cytoskeleton, clustering 
both Fasll and Shaker K+ channels, forming a stabilization complex that must be 
disassociated so that synaptic outgrowth can occur (Thomas et al., 1997; Zito et 
al., 1997; Tejedor et al., 1997). In Ap/ysia, it has been shown that Fasll is directly 
phosphorylated by ERKIMAPK, which results in the internalization of Fasll and 
the disassociation of the DLG-Fasll stabilization complex (Bailey et al., 1997). 
Activated ERK has also been shown to displace Fasll at the motor neuron 
terminus, resulting in increased synaptic growth (Koh et al., 2002). Our data 
indicate that both the Ras-ERK and PI3K cascades are cooperatively involved in 
motor neuron synaptic outgrowth. We hypothesize that Ras-ERK is required to 
downregulate Fasll from the stabilization complex and that PI3K activation 
regulates protein translation via S6K (Howlett et al., 2008) to promote bouton 
formation (Fig.3.4) 
CamKII also promotes synaptic outgrowth by phosphorylating and removing 
DLG from the DLG-Fasll complex (Koh et al., 1999). Our lab has recently 
reported that we can rescue the growth defect associated with expression of the 



















Figure 3.4: Synaptic outgrowth requires the activity of several pathways. 
Signaling pathways involved in the downregulation and the initiation of 
transcription/translation appear to be involved in the regulation of synaptic 
outgrowth. The Discs-Large (DLG) and Fascilin II (Fasll) cell adhesion complex 
stabilize the synapse by clustering components of the cell's cytoskeleton and the 
Shaker K channel (Thomas et al., 1997; Zito et al., 1997; Tejedor et al., 1997). 
This complex must be destabilized in order for outgrowth to occur. CaMKII and 
ERK promote outgrowth by phosphorylating and thus downregulating DLG and 
Fasll, respectively (Bailey et al., 1997; Koh et al., 2002; Koh et al., 1999). PI3K 
also regulates outgrowth, most likely through regulating transcription (Howlett et 
al., 2008). CaMKII and PI3K are not sufficient to promote outgrowth in the 
absence of ERK signaling (this study and preliminary, unpublished data); 
therefore ERK activation appears to be requirement for outgrowth. In addition to 
Fasll, ERK may regulate additional targets that are required for outgrowth 
processes. 
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study found that the expression of P/3K-CAAX could not block the synaptic deficit 
associated with inhibiting Ras-ERK signaling (Fig.3.3), suggesting that intact 
Ras-ERK signaling is required for the effects of CaMKII and PI3K on synaptic 
growth. Because both CamKII and ERK modulate the DLG-Fasll complex 
indicates that these molecules may be altering the complex in a different manner 
(i.e., ERK phosphorylation may more efficiently remove the complex). ERK may 
additionally have other targets distinct from CamKII that are involved in this 
process, including the transcription factor CREB, which has been shown to 
participate in neurite outgrowth in cultured sensory cells (Schmid et al., 1999; 
White et al., 2000). 
Chapter 4: DmGiuRA activation of ERK 
4.1 Introduction 
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4.1.1 Overview of the biochemistry and function of the extracellular 
signal-related kinase (ERK) 
The highly conserved mitogen-activated protein kinase (MAPK) families of 
signaling molecules are essential for the transmission of extracellular information 
into intracellular activities. Presently, four distinct MAPK cascades, which include 
extracellular signal-related kinase (ERK), c-Jun N-terminal kinase (JNK), p38, 
and Bruton's tyrosine kinase (BMK) have been indentified that participate in a 
wide-range of cellular function including the regulation of proliferation, 
differentiation, survival, apoptosis, and cellular migration (reviewed in Shaul and 
Seger, 2007). The ERK molecules and their related signaling cascades are of 
particular interest to neurobiology because they are highly expressed in the 
neurons of the central nervous system and appear to have a critical role in the 
processes of learning and memory (reviewed in Adams and Sweatt, 2002). 
The transmission of signals through the related MAPK cascades occurs by 
the sequential activation of several sets of protein kinases (Fig.4.1 ). Signaling 
through the ERK cascade is typically initiated via the activation of Ras in 
response to growth factors and other extracellular stimuli. Ras activation recruits 
and activates a second protein kinase, Raf, at the plasma membrane (Wellbrock 
et al., 2004). Raf phosphorylates and activates the enzyme MAPKIERK kinase 
(MEK), which in tum phosphorylates and activates ERK1 and ERK2 (also known 
as p44 and p45 kinase, respectively) (Nakielny et al., 1992) (Fig. 4.1). Activated 
1 Upstream signal 
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Figure 4.1: Overview of the Ras-ERK signal transduction pathway. The 
activation of extracellular signal-related kinase, ERK, a member of the 
mitogen-activated protein (MAP) kinase family, occurs through the sequential 
activation of several sets of kinases. The activation of Ras via receptor-
tyrosine kinases or G protein-coupled receptors typically initiates the cascade. 
Activated Ras-GTP recruits and activates Raf at the plasma membrane. Raf 
phosphorylates and activates the enzyme MAP kinase kinase (MEK) which in 
turn phosphorylates and activates ERK1 and ERK2. ERK1/2 is involved in the 
regulation of a multitude of transcription factors, including cyclic-AMP 
response element binding protein (CREB) (Wellbrock et al., 2004; Nakielny et 
al. , 1992; Shaul and Seger, 2007). 
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ERK phosphorylates a large number of substrates in the cell cytoplasm and in 
the nucleus including the transcription factors Elk1 , c-Fos, p53, and c-Jun 
(reviewed in Shaul and Seger, 2007). ERK is also involved in the regulation of 
the activity of the transcription factor cyclic-AMP response element binding 
protein (CREB) via another set of kinases; the ribosomal S6 kinases (RSKs) and 
the mitogen- and stress-associated protein kinases (MSKs) (Hardingham et al., 
2001; Xing et al., 1998; Deak et al., 1998). Many studies have indicated that 
CREB-dependent transcription is critical for learning and memory) (reviewed in 
Thomas and Huganir, 2004 ). 
4.1.2 ERK signaling is involved in synaptic plasticity in vertebrates 
Two forms of synaptic plasticity, LTD and L TP, which modify the strength of 
synaptic connections via changes in excitability, are widely believed to be integral 
for learning and memory by "encoding" distinct activity patterns within a neural 
network (Bruei-Jungerman et al., 2007; Davis, 2006; Katz and Shatz, 1996; Bliss 
and Collingridge, 1993). Research over the past decade has revealed that the 
regulation of the ERK signaling cascade plays a significant role in synaptic 
plasticity via the alteration of L TO and L TP in hippocampal and cortical neurons 
(Peng et al., 2010; Thomas and Huganir, 2004). Following LTP-inducing stimuli, 
phosphorylated ERK (p-ERK; activated) immunoreactivity develops rapidly in 
dendritic and somatic regions of hippocampal neurons, indicating that ERK 
substrates are found throughout the neuron (Davis et al., 2000; Dudek and 
Fields, 2001 ). Additional studies using rat hippocampal or cortex slices found that 
the application of the specific MEK pharmacological inhibitor PD98059 effectively 
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blocks LTP induction in these tissues (English and Sweatt, 1997; Dicristo et al., 
2001 ). Injection of PD98059 into the brain also alters the memory performance of 
rats in several types of memory-related behavioral tests (Blum et al., 1999; 
Berman et al., 1998), further substantiating the role of LTP in memory formation. 
Numerous studies have demonstrated a requirement for ERK activity in several 
forms of synaptic plasticity including NMDA receptor independent forms of LTP, 
L TP induction in the dentate gyrus, and L TP in the amygdala, which is involved in 
fear conditioning (reviewed in Thomas and Huganir, 2004). Inhibiting ERK 
signaling also mediates L TO in Purkinje cells; however, this effect appears to be 
due the direct modulation of mGiuR function by ERK rather than ERK functioning 
in a downstream signaling event related to LTD (Kawasaki et al., 1999). 
The underlying mechanisms regarding ERK signaling and how it relates to the 
processes mediating LTP and LTD have been debated, though a great deal of 
evidence suggests it may occur via the modification in the number or activity of 
postsynaptic AMPA receptors or through the activity-dependent modification of 
dendritic spines (reviewed in Thomas and Huganir, 2004). These processes 
appear to be regulated by the effect ERK signaling on transcription and protein 
translation (reviewed in Peng et al., 2010). Transcription factors, such as Elk1 
and CREB, may be important targets of ERK in the regulation of synaptic 
plasticity. Though many studies have found a requirement for ERK in the 
regulation of the processes that regulate synaptic plasticity, still little is known 
concerning the molecular components that activate this pathway. It is generally 
accepted that the ERK signaling cascade in neurons is initiated by activated Ras 
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(Margolis and Skolnk, 1994; Downward, 1996), in response to membrane 
depolarization (Rosen et al., 1994), or by G-coupled protein receptors (reviewed 
in Goldsmith and Dhanasekaran, 2007); however, which of these upstream 
components are modulating the activation of ERK in the processes related to 
synaptic plasticity are not clear. 
4.1.3 mGiuR activation initiates ERK signaling during L TP and LTD 
As critical regulators neural excitatory transmission, mGiuRs are important for 
the modulation of synaptic plasticity. mGiuR mediated L TO, termed mGiuR-L TO, 
results in a long-lasting decrease in synaptic strength and efficiency in response 
to low frequency simulation or to the application of group I mGiuR agonists 
(reviewed in Gladding, 2009). The molecular mechanisms underlying induced 
mGiuR-L TO have not been elucidated fully; however, many studies have 
demonstrated that protein synthesis is required to maintain LTD (reviewed in 
Gladding, 2009). Work from a number of groups has established that the ERK 
and the PI3K-mTOR signaling pathways are involved in coupling mGiuR 
activation to translational machinery during L TO (Gladding et al., 2009; Antion et 
al., 2008; Banko et al., 2006; Gallagher et al., 2004; Hou and Klann, 2004; 
Sweatt, 2004). In the hippocampus, the activation of the initiation factor eiF4E 
and the S6 ribosomal proteins, key steps in the initiation of cap-dependent 
protein translation, are dependent on ERK phosphorylation (Antion et al., 2008; 
Kelleher et al., 2004; Banko et al., 2004). Blocking ERK signaling, thereby 
disrupting cap-dependent translation, inhibits mGiuR-L TD (Gallagher et al., 2004; 
Huber et al., 2000). 
82 
The molecular mechanisms underlying the initiation of the ERK cascade via 
mGiuR are not completely understood and appear to vary depending on the 
neural tissue type and the method of induction. As G protein-coupled receptors, 
the activation of group I mGiuRs can initiate a Ca2+ -dependent signaling cascade 
via the activation of the effector phospholipase C (PLC), which results in an 
increase in inositol triphosphate (IP3) and diacylglycerol (DAG) production that 
ultimately results in the release of Ca2+ from intracellular stores (Gladding et al., 
2009; Pin and Ouvoisin, 1995). This pathway has been previously demonstrated 
to activate ERK (Hermans and Challiss, 2001 ). The scaffolding protein Homer 
may also couple the group I mGiuRs to ERK signaling in a Ca2+ -independent 
manner (Mao et al., 2005). The adaptor protein, caveolin-1, which associates 
with lipid rafts and negatively regulates endocytosis (Nabi and Le, 2003), has 
additionally been shown facilitate mGiuR-dependent ERK signaling (Francesconi 
et al., 2009). The canonical ERK cascade activator, Ras, has also been 
suggested to play a role in mGiuR-mediated ERK activation; however, this is not 
due to the direct activation of Ras by mGiuRA and requires calcium influx 
(Walker et al., 2002). 
L TO can be also be induced by the electrical and chemical stimulation of the 
presynaptic group II mGiuRs (Aitinbilek and Manahan-Vaughan, 2009; Poschel 
and Manahan-Vaughan, 2005; Manahan-Vaughan, 1997; Huang et al., 1997); 
however, much less is known regarding the molecular mechanisms governing 
the effect of the presynaptic group II mGiuRs on L TO. Agonist-activation of 
group II mGiuRs in the vertebrate hippocampus was previously demonstrated to 
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activate ERK in the glia and interneurons (Berkeley and Levey, 2003) indicating 
that the ERK cascade may also be involved in the effects of the group II mGiuRs 
on synaptic plasticity. 
4.1.4 Glutamate-activated DmGiuRA initiates ERK signaling 
The Drosophila larval nmj is a tractable system to investigate the molecular 
mechanisms governing synaptic plasticity due to the ease of accessing 
identifiable synapses (Keshishian et al., 1996) and the fact that both short and 
long terms of plasticity have been demonstrated to occur at the nmj (Guo and 
Zhong, 2006; Broadie et al., 1997; Jan and Jan, 1978). As discussed in 
previous chapters, Drosophila has a single metabotropic glutamate receptor, 
DmGiuRA, a G protein-coupled receptor that is most similar to the vertebrate 
group II mGiuRs (Bogdanik et al., 2004; Parmentier et al., 1996). In vertebrates, 
the activation of both the group I and group II mGiuRs during the induction of 
either L TP or L TO, appears to involve the ERK cascade; however, to our 
knowledge, it is unknown if ERK signaling is similarly initiated by DmGiuRA 
activation. 
The ERK cascade is involved in neural signaling and has been demonstrated 
to participate in mGiuR-mediated effects on synaptic plasticity (Peng et al., 2010; 
Thomas and Huganir, 2004; Lonze et al., 2002; Davis et al., 2000; Dudek and 
Fields, 2001 ). The presynaptic group II mGiuRs also regulate L TO; however, the 
mechanisms governing these processes are relatively unexplored. It was 
previously demonstrated that agonist-activation of the group II mGiuRs in the 
hippocampus results in an increase in ERK phosphorylation in the glia and 
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intemeurons (Berkeley and Levey, 2002); therefore we wanted to investigate if 
the activation of DmGiuRA initiates ERK in the Drosophila motor neuron. 
Elucidating a connection between DmGiuRA activation and ERK signaling in 
Drosophila may uncover a similar mechanism related to the group II mGiuRs in 
vertebrates. 
To assess if the activation of DmGiuRA via glutamate initiates the ERK 
cascade, we first examined if the application of glutamate increased the level of 
phosphorylated ERK (p-ERK) in the motor neuron and confirmed that the 
increase in p-ERK required DmGiuRA activity. We found that the application of 
glutamate to the larval nmj increases p-ERK and that this increase is dependent 
on DmGiuRA. We then used a series of transgenes to alter the activity of several 
molecules potentially involved in the activation of ERK in the neuron to 
investigate potential signaling intermediates. We determined that unlike the 
initiation of the PI3K cascade via DmGiuRA, that CaMKII and DFak are not 
involved in the activation of ERK. We also unexpectedly found that inhibiting Ras, 
the principle activator of the ERK signaling cascade, resulted in a significant 
increase in the basal levels of p-ERK; whereas knocking down the Ras effector 
Raf decreased ERK activity. These results suggest that DmGiuRA activates 
ERK and PI3K via separate pathways; however, the signaling components 
involved in DmGiuRA-mediated ERK activation remain undefined. 
4.2 Materials and Methods 
4.2.1 Fly husbandry and stocks 
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All fly stocks were maintained as described in previous chapters and 
experimental crosses ( 1 0 male and 1 0 female) were prepared in bottles and 
adults were passaged every four days to limit the overcrowding of larvae. The 
GAL4 driver stock utilized for these experiments was the motor neuron driver, 
D42-GAL4. 
To evaluate the DmGiuRA activation of ERK, we used the DmGiuRA null 
mutant, DmG/uRA 112b that was produced via the transponson excision of the start 
codon and a portion of the extracellular ligand binding domain of DmGiuRA 
(Bogdanik et al., 2004) (Bloomington). In addition to the Ras-RNAi transgene 
previously described, also we used a dominant-negative Raf transgene, UAS-
RafN, which has a lysine to methionine substitution at residue 497 (K497M) 
(Bloomington Stock Center). We additionally utilized an inositol triphosphate 
receptor RNAi transgene, UAS-IP3R-RNAi (Drosophila Genetic Resource Center, 
Kyoto, Japan) and a constitutively active CaMKII transgene, UAS-CamKIIT2870 
that has a phosphomimetic threonine to aspartate substitution in the 
autophosphorylation site (T287D) (Fong et al., 1989) provided by Leslie Griffith 
(Brandeis University). A null mutation in Drosophila focal adhesion kinase, 
DFaifG1 was provided to us by Ruth Palmer, Umea University, Sweden. 
4.2.1 Larval anti-phosphorylated ERK (p-ERK) analysis 
These experiments were performed similarly to the anti-p-Akt experiments 
previously described in Chapter 3. Wandering, third instar larvae were collected 
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from the sides of bottles within an appropriate window of time (48 hours) and 
dissected for immunohistochemistry using Drosophila S2 media as described in 
Chapter 2. To detect levels of activated ERK (phosphorylated ERK, p-ERK) we 
utilized a monoclonal, anti-ERKIMAP Kinase antibody (Sigma) (1 :20) that 
recognizes the two phosphorylated Thr202 and Tyr204 residues in the regulatory 
site of ERK that are required for the full activation of the kinase. This antibody 
does not recognize the monophosphorylated or non-phosphorylated forms of 
ERK. This anti-p-ERK antibody has been previously used in the Drosophila nmj 
(Koh et al., 2002; Tsai et al., 2008). The confocal microscopy and data analysis 
were performed as described for the p-Akt experiments described previously in 
Chapter 2. 
4.3 Results for the anti-p-ERK analysis 
4.3.1 Glutamate-activated DmGiuRA increases p-ERK in the motor 
neuron 
In vertebrates, the neural modulatory events involved in synaptic plasticity 
appear to involve the activation of mGiuRs and ERK. It is widely accepted that 
mGiuR-L TD involves ERK signaling (Peng et al., 201 0; Gladding, 2009; Antion et 
al., 2008; Banko et al., 2006; Gallagher et al., 2004; Thomas and Huganir, 2004 ). 
The pharmacological activation of group II mGiuRs in the hippocampus have 
additonally been shown elevate levels of p-ERK in the glia and interneurons 
(Berkeley and Levey, 2003). To investigate if the activation of DmGiuRA involves 
ERK signaling in Drosophila, we applied 1 00 IJM of glutamate to the larval nmj 
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and examined the induction of ERK signaling via anti-p-ERK immunostaining. We 
found that the application of glutamate to wildtype larval nmjs resulted in a 
significant increase in the levels of p-ERK (Fig. 4.2). Analysis of the null mutant 
DmG/uRA 112b revealed significantly lower, basal levels of p-ERK (Fig.4.2). We 
also found that the application of glutamate did not result in an increase in p-ERK 
immunoreactivity (Fig.4.2). These results indicate that activated DmGiuRA 
initiates ERK signaling in the Drosophila motor neuron. 
4.3.2 Blocking the release of intracellular Ca2+ from the endoplasmic 
reticulum has no effect DmGiuRA-ERK signaling 
The ERK pathway has been demonstrated to be a target of neuronal Ca2+ 
signaling (Wiegert and Bading, 201 0; Grewal et al., 2000). Our lab previously 
found that the activation of DmGiuRA increases intracellular Ca2+ (unpublished 
data). We have also recently demonstrated that the Ca2+-Calmodulin dependent 
kinase, CaMKII, is an integral component of activated DmGiuRA signaling (Lin et 
al., 2011 ). To investigate if DmGiuRA activates the ERK cascade via the release 
of intracellular Ca2+ from the endoplasmic reticulum (ER), we expressed an 
inositol 1 ,4,5-triphospate receptor-RNAi (IP3R-RNAi) transgene in the motor 
neuron. Expression of this transgene decreased the basal levels of p-ERK 
(Fig.4.2); however, we found that the inhibition of the IP3R did not block the 
glutamate-induced increase in p-ERK, suggesting that DmGiuRA activation of 
ERK may not involve the release of Ca2+ from the ER. 
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Figure 4.2: ERK activation occurs via a distinct DmGiuRA-mediated 
pathway. Anti-p-ERK immunoreactivity was measured before and after the 
application of 100 !JM ~utamate for 042>+ (control), OmG/uRA 112b, 042>/P3R-
RNAi, 042>CaMKJIT28 (basal only), OFakcG1, 042>Ras-RNAi, 042>RafN. 
Means +/- SEMs of normalized pixel intensities (Y-axis) of the indicated 
genotypes (X-axis ). The pixel intensity of the anti-p-ERK staining was averaged 
for each genotype and normalized to the average intensity of the control 
preparation: values from OmG/uRA 112b, OFakcG1 were normalized to WT (not 
shown), whereas values from 042>/P3R-RNAi, 042>CaMKIIT2870, 042>Ras-
RNAi, and 042>RafN were normalized to 042>+. For all genotypes, n=30. 
One-way ANOVA and Fisher's LSD were used to find the following significant 
differences: WT vs. OmG/uRA 112b, p=0.005; 042>+ vs. 042>/P3R-RNAi, 
p=0.036, vs. 042>Ras-RNAi, p=0.028; vs. 042>RafN, p=0.008. No significant 
differences were found for the following comparisons: WT vs. OFakcG1, p=0.069; 
042>+ vs. 042>CaMKIIT2870, p=0.395. 
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4.3.3 CaMKII is not involved in DmGiuRA-ERK signaling 
The activation of ERK during group I mGiuR- LTD was previously shown to 
involve CaMKII (Zhu et al., 2002; Choe and Wang, 2001 ). We have also shown 
that CaMKII is an important signaling intermediate for DmGiuRA-mediated PI3K 
activation (Lin et al., 2011 ). To investigate if DmGiuRA may also activate ERK 
via CaMKII, we expressed the constitutively-active CaMKIIT2870 transgene in the 
Drosophila motor neuron. If CaMKII was involved in the activation of the ERK 
cascade, we expected to observe an increase in the level of p-ERK in the 
neuron; however, we observed no difference in the basal levels of p-ERK 
compared to wildtype (Fig.4.2) which suggests that CaMKII does not participate 
in the activation of ERK. 
4.3.4 Drosophila Focal adhesion kinase (DFak) is not involved in the 
activation of ERK by DmGiuRA 
The non-receptor tyrosine kinase Fak is involved in numerous cellular 
responses including cell adhesion, migration, differentiation (reviewed in 
Parsons, 2003) and can be activated by G-coupled protein receptors via CamKII; 
(Fan et al., 2005). We have recently demonstrated that DFak is epistatic to 
CaMKII during glutamate-activated DmGiuRA-PI3K signaling (Lin et al., 2011 ); 
therefore we wanted to investigate if DFak also participates in ERK activation. 
We examined the levels of p-ERK immunoreactivity in the null mutant, DFalfG1 
and found that the basal levels of p-ERK were not significantly different than 
wildtype. We also found that the glutamate-evoked increase in p-ERK is not 
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blocked in this mutant (Fig.4.2), indicating that DFak is not involved in DmGiuRA-
mediated ERK signaling. 
4.3.3 Inhibiting Ras activity increases basal levels of p-ERK in the motor 
neuron 
The canonical ERK activation pathway involves the activation of the Ras-Raf-
MEK-ERK cascade (Wellbrock et al., 2004; Nakielny et al., 1992). During the 
course of this study, we have found that Ras is a critical intermediate in the 
DmGiuRA-PI3K regulation of neural excitability. To investigate if Ras is 
additionally involved in the activation of ERK via DmGiuRA, we expressed Ras-
RNAi in the motor neuron and examined levels of p-ERK. Unexpectedly, 
expression of Ras-RNAi resulted in a significantly higher, basal level of p-ERK 
(Fig 4.2). The application of glutamate to the nmj did not further increase p-ERK 
immunoreactivity in the neuron (Fig.4.2), indicating that either Ras-RNAi blocks 
an additional increase in p-ERK, or that the maximum levels of detectable p-ERK 
have been reached. 
To additionally explore the role of the canonical Ras-Raf pathway on ERK 
activation, we also examined the modulation of the kinase Raf. We found that 
expression of a dominant-negative Raf transgene (RafN) in the motor neuron 
decreased the basal levels of p-ERK (Fig.4.2). Expression of this transgene also 
blocked the glutamate-induced increase in p-ERK (Fig.4.2). This result 
tentatively indicates that Raf is involved in the DmGiuRA activation of ERK; 
however, the discrepancies between this result and the Ras-RNAi result make it 
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difficult to conclude if the Ras-Raf pathway is involved in ERK activation via 
DmGiuRA. 
4.4 Discussion 
4.4.1 Activated DmGiuRA initiates ERK signaling 
In vertebrates, the ERK cascade has been shown to be important for group I 
mGiuR-L TD by regulating gene transcription and translation (Francesconi et al., 
2009; Antion et al., 2008; Banko et al., 2006; Gallagher et al., 2004; Hou and 
Klann, 2004). The group II mGiuRs also modulate LTD (Aitinbilek and Manahan-
Vaughan, 2009); and agonist-activation of these receptors has been found to 
increase p-ERK in the glia and the intemeruons (Berkeley and Levey, 2003); 
however, little else is known concerning the molecular components that may be 
involved in the regulation of LTD by this receptor. We have found that the 
application of glutamate to the larval nmj increases the levels of p-ERK in the 
motor neuron (Fig.4.2). This increase was blocked by the DmGiuRA null mutant, 
indicating that DmGiuRA is required for glutamate-induced ERK activation. To 
our knowledge, this is the first demonstration that glutamate-liganded DmGiuRA 
activates ERK signaling in the Drosophila motor neuron and may prove to be a 
conserved signaling mechanism for the presynpatic group II mGiuRs in 
vertebrates. 
4.4.2 Inhibiting the IP3 receptor does not block DmGiuRA activation of 
ERK 
The group I mGiuRs activate ERK during mGiuR-LTD (Peng et al., 2010; 
Thomas and Huganir, 2004; Lonze et al., 2002; Davis et al., 2001; Dudek and 
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Fields, 2001 ). This activation may occur via the activation of PLC-IP3 (Gladding 
et al., 2009; Hermans and Challiss, 2001; Pin and Duvoisin, 1995). Though 
sequence analysis has indicated that DmGiuRA is most similar to the group II, 
which primarily inhibit adenylyl cyclase (Schoepp, 2001 ), because DmGiuRA is 
the only mGiuR in Drosophila, it has been proposed to function similarly to the 
group I (Bogdanik et al., 2004; Parmentier et al., 1996). Activated PLC cleaves 
the PIP2 into inositol 1 ,4,5-triphospate (IP3) which binds to the IP3 receptors 
(IP3R) of the ER, releasing Ca2+ into the cell. Our lab additionally found that the 
activation of DmGiuRA via glutamate increases the level of intracellular Ca2+ in 
the motor neuron (unpublished data) further suggesting that PLC- IP3 may be 
activated. We wanted to investigate the possibility that DmGiuRA was activating 
ERK via the release of Ca2+ from the intracellular stores of the endoplasmic 
reticulum (ER). We found that the expression of an IP3R-RNAi transgene lowered 
the basal levels of p-ERK; however this transgene did not block the glutamate-
stimulated increase in p-ERK (Fig.4.2). This result suggests that either DmGiuRA 
does not activate the PLC-IP3 pathway releasing Ca2+ from the ER, or that ERK 
is not activated by DmGiuRA via Ca2+. 
We have recently shown that CaMKII, a kinase whose activity relies on Ca2+, 
is a critical signaling intermediate for DmGiuRA-mediate PI3K activation (Lin et 
al., 2011 ). We hypothesized that DmGiuRA activation is a Ca2+ -dependent 
process. Activated DmGiuRA could be activating ERK via a process that does 
not involve the IP3R- mediated release of Ca2+ from the ER. One of these 
possibilities could be the activation of the ryanodine receptor (RyR), which has 
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been found to play a role in supplying Ca2+ in mammalian nerve terminals (Collin 
et al., 2005; Verkhratsky, 2002). It is also possible that glutamate stimulates an 
increase in Ca2+ by triggering extracellular Ca2+ influx via voltage gated channels. 
It has been well-established that Ca2+ channels are regulated by the binding of 
the G~y-subunit, though this interaction is typically inhibitory (de Waard et al., 
2005; Tedford and Zamponi, 2006) it still might be possible that DmGiuRA 
activates Ca2+ influx though these channels. 
4.4.3 DmGiuRA activates PI3K and ERK via distinct pathways 
In the vertebrate hippocampus, the activation of ERK was demonstrated 
occur via CaMKII during mGiuR-LTD (Zhu et al., 2002). Our lab has recently 
shown that both CaMKII and DFak are critical signaling intermediates during the 
activation PI3K by DmGiuRA in the Drosophila motor neuron (Lin et al., 2011 ). 
Because the activation of DmGiuRA by glutamate increases p-ERK in the 
neuron, we wanted to additionally investigate if CaMKII or DFak are required for 
DmGiuRA-mediated ERK signaling. We examined the basal levels of p-ERK in 
neurons expressing a constitutively-active CamKII transgene and found no 
increase in p-ERK. In the null mutant Fa~G1 , the basal levels of p-ERK were 
slightly reduced; however, the increase in p-ERK after glutamate application was 
not blocked in this mutant. These results indicate that CaMKII and DFak are not 
involved in the DmGiuR-mediated activation of ERK. 
4.4.4 Additional molecules involved in Raf activation may be 
responsible for increasing basal levels of p-ERK in response to diminished 
Ras activity 
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Canonical ERK signaling occurs via the activation of the Ras-Raf-MEK-ERK 
cascade in response to growth factors and other stimuli. We have now also 
demonstrated that Ras is required for the glutamate-activation of PI3K via 
DmGiuRA. Because Ras is a widely-accepted activator of the ERK pathway, we 
investigated the if Ras and Raf are involved in DmGiuRA-mediated ERK 
signaling. 
Unexpectedly, we found that inhibiting Ras in the motor neuron with Ras-
RNAi increased the basal level p-ERK compared to wildtype (Fig.4.2). The 
application of glutamate did not further increase p-ERK levels; however, we do 
not know if this is because the RNAi is blocking an additional increase in ERK or 
if we reached the maximum detectible limits of p-ERK in the neuron. Though the 
inhibition of Ras produced a highly unusual result, knocking down the activity of 
Raf more predictably reduced the basal levels of p-ERK and blocked the 
glutamate-induced increase in p-ERK in the motor neuron (Fig). This observation 
agrees with the canonical signaling pathway and tentatively suggests that Raf is 
a DmGiuRA-ERK signaling intermediate. 
It is unclear why knocking down Ras in the Drosophila motor neuron resulted 
in a significant increase in p-ERK immunoreactivity. One hypothesis is that the 
inhibition of Ras unbalanced a complex set of regulatory mechanisms that 
normally modulate the activity of the Ras-ERK pathway. There are a multitude of 
additional proteins that are known to participate in the regulation of the Ras-ERK 
pathway; however, their exact modes of action, especially in the Drosophila 
motor neuron, are not well-understood. One of these molecules is the tyrosine 
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protein kinase Src homolog at 648 (Src648) that has been proposed to function 
in a pathway similar to Ras during neural development and alters synaptic 
outgrowth in Drosophila (Kussick et al., 1993; Tsai et al., 2008). Src648 can bind 
to and activate Rat in a Ras-independent manner indicating that like Ras, Src648 
can also activate ERK signaling (Xia et al., 2008). Src648 is also predicted to 
interact with Ras (String Database, http://string-db.org and BioGRID version 3.1, 
http://thebiogrid.org), suggesting that in addition to activating Rat, Src648 may 
also effect Ras activity. 
Other members of the Ras superfamily that have been identified at the 
synapse that might be involved in the activation of ERK are the Rap GTPases, 
Rap1 and Rap2 (Peng et al., 2004; Pizon et al., 1988). Rap1 has been shown to 
alter excitability via the activation of ERK downstream group I mGiuR in 
mammalian pyramidal cells (Morozov et al., 2003}. Conversely, Rap2 is a 
negative regulator of dendritic spine growth and ERK signaling (Ryu et al., 2008). 
It has been proposed that Rap1 and Rap2 negatively regulate synaptic strength 
by opposing the activity of Ras (Fu et al., 2007; Zhu et al., 2005; Pak et al., 
2001 ); however their exact function in neurons remain undefined. Drosophila 
Rap1 (Dras3) is 88°/o identical to human Rap1 (Hariharan et al., 1991 ), and 
therefore may similarly activate ERK like its vertebrate ortholog. The activity of 
the Rap molecules could potentially alter basal ERK activity in the absence of 
Ras in the motor neuron; however, these interactions remain to be explored. 
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Chapter 5: Synopsis 
5.1 Ras dependent and independent activation of PI3K in the 
Drosophila motor neuron 
5.1.1 The effects of PI3K on neural excitability requires Ras 
The signal transducer, PI3K, participates in the mediation of a myriad of 
cellular processes in response to insulin-signaling, growth factors, and signals 
related to cell survival (reviewed in Engleman et al., 2006). PI3K is also 
recognized as an intermediary of synaptic growth and neural function (lwanami et 
al., 2009; Endersby and Baker, 2008). Two forms of synaptic plasticity, long-
term depression (L TO) and long-term potentiation (L TP), which involve changes 
in neural excitability that are believed to "pattern" learning and memory in the 
animal brain (Davis, 2006; Martinet al., 2000; Bear, 1994; Bliss and Collingridge, 
1993), are governed in part by PI3K-mediated signaling (Sharma et al., 2010; 
Gladding, 2009; Bourgeois, 2009; Hou and Klann, 2004; Man et al., 2003). 
Abnormalities in L TP and LTD have been linked to autism (Rubenstein and 
Merzenich, 2003) and several significant neurological diseases that have co-
morbidity with autism, including Fragile X Syndrome (FXS), Neurofibromatosis-1 
(NF1 ), and Tuberous sclerosis {TSC), exhibit altered PI3K signaling (Bourgeois, 
2009; Cusc6 et al., 2009; Kelleher and Bear, 2008; Grosset al., 2010; Levitt and 
Campbell, 2009; Williams et al., 2008; Kwon et al., 2006). Defining the molecular 
elements that regulate PI3K may identify useful therapeutic targets for these and 
other related neurological disorders. 
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The metabotropic glutamate receptors (mGiuRs) regulate neural excitability 
and have been implicated in a number of diseases including anxiety, epilepsy, 
and schizophrenia (Enz, 2007; Chapman et al., 1996). The group I mGiuRs are 
involved in the establishment of L TP and LTD (Aitinbilek and Manahan-Vaughan, 
2009; Holscher et al., 1999; Manahan-Vaughan, 1997) and an abnormally 
enhanced L TO, believed to be the result of aberrant mGiuR signaling, has been 
found in mouse models of FXS (Pfeiffer and Huber, 2009; Ronesi and Huber, 
2008; Muddashetty et al., 2007; Banko et al., 2006; Koekkoek et al., 2005; Huber 
et al., 2002). Elevated PI3K activity, suspected to be the result of abnormal 
mGiuR-L TO, has additionally been observed in FXS, resulting in aberrant 
synaptic translation and excess dendritic spine growth (Sharma et al., 2010; 
Gross et al., 2010; Hou and Klann, 2004). The group I mGiuRs have been 
suggested to activate PI3K during mGiuR-L TD via the scaffolding protein Homer 
(Ronesi and Huber, 2008), although the activation of PI3K via this mechanism 
has not been demonstrated. The presynaptic group II mGiuRs additionally 
appear to be involved in the establishment of LTD (Aitinbilek and Manahan-
Vaughan, 2009; Poschel and Manahan-Vaughan, 2005). Our lab has shown that 
the activation of the Drosophila mGiuR ortholog, DmGiuRA, which is most similar 
to the vertebrate group II mGiuRs, initiates PI3K signaling in the motor neuron 
(Howlett et al., 2008). The group II receptors lack the Homer-binding motif found 
in the group I (Diagana et al., 2002), therefore the mechanisms by which 
DmGiuRA may be facilitating the activation of PI3K is not clear. 
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Similar to PI3K, the GTPase Ras has been demonstrated to modulate 
synaptic structure and function, as well as participate in the establishment of L TP 
and LTD (Ye and Carrow, 2010; Kumar et al., 2005; Jarwoski et al., 2005; Arendt 
et al., 2004; Markus et al., 2002). PI3K is a known effector of Ras (Orme et al., 
2006; Rodriguez-Viciana et al., 1994); however, which PI3K-mediated neural 
processes require Ras has not been clearly defined. We have now demonstrated 
that the activation of PI3K via glutamate-liganded DmGiuRA requires Ras and 
that the activity of Ras alters the effect of PI3K on neural excitability in the 
Drosophila motor neuron. 
We have shown that the inhibition of Ras via transgene expression and 
chromosomal loss-of-function blocks the ability of DmGiuRA to activate the PI3K 
signaling cascade as measured by the levels of p-Akt (Fig.2.5). PI3K is crucial for 
the regulation of neural excitability by DmGiuRA and diminished PI3K signaling 
results in an abnormal increase in neural excitability that we have previously 
shown is mediated by the inhibition of dFOXO by PI3K-Akt signaling (Howlett et 
al., 2008). We found that inhibiting Ras results in a hyperexictable, neural 
phenotype (Fig.2.7) consistent with decreased PI3K signaling (Howlett et al., 
2008). Furthermore, the observation that the Ras-insensitive PI3K variant, gen-
P/3~80, is hyperexcitable (Fig.2. 7) additionally indicates that Ras is a critical 
component in the DmGiuRA-PI3K mediated regulation of motor neuron 
excitability. 
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5.1.2 The effect of PI3K on synaptic outgrowth is Ras-independent 
Alterations in synaptic structure and morphology have been identified in 
several neurological disorders hallmarked by ASD, including FXS (Kaufmann and 
Moser, 2000; Restivo et al., 2005). As previously discussed, PI3K signaling is 
involved in the processes that modify synaptic strength (Sharma et al., 201 0; 
Gladding, 2009; Bourgeois, 2009; Hou and Klann, 2004; Man et al., 2003) and 
outgrowth (Akiyama and Kamiguchi, 201 0; Vodrazka et al., 2009; Brandt et al., 
2007; Jossin and Goffinet, 2007; Kumar et al., 2005; Jaworski et al., 2005; 
Markus et al., 2002). Aberrant PI3K signaling is implicated in several neurological 
disorders (Gross et al., 201 0; Bourgen, 2009; Cusc6 et al., 2009; Kelleher and 
Bear, 2008; Levitt and Campbell, 2009; Williams et al., 2008; Kwon et al., 2006), 
underlining the importance of understanding the signaling pathways that regulate 
neural form and function. 
Both activated Ras and PI3K have been demonstrated to participate in 
synaptic outgrowth (Akiyama and Kamiguchi, 201 0; Vodrazka et al., 2009; Fivaz 
et al., 2008; Brandt et al., 2007; Oinuma et al., 2007; Jossin and Goffinet, 2007; 
Romero et al., 2007; Kumar et al., 2005; Jaworski et al., 2005; Markus et al., 
2002); however, in addition to PI3K, Ras is positioned to activate a second 
signaling cascade, the ERK cascade, that has also been demonstrated to alter 
synaptic outgrowth (Kumar et al., 2005; Jaworski et al., 2005; Arendt et al., 2004; 
Markus et al., 2002; Koh et al., 2002). Deciphering the downstream specific 
activity of Ras has been important for the effective treatment of human cancers 
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(McCubrey et al., 2006) and therefore may also be important for the development 
of neurological disease therapies. 
We found that effect of PI3K on synaptic growth is Ras-independent. Though 
inhibiting Ras activity diminished outgrowth (Fig.3.2), similar to what is observed 
when PI3K activity is decreased (Howlett et al., 2008; Martin-Peiia et al., 2006), 
we found that expressing PI3K did not block the effect of Ras inhibition on growth 
(Fig.3.3). This observation is consistent with a previous report that found that the 
expression of a constitutively-active Ras transgene that only activates the PI3K 
effector pathway (Rasv12C4°) failed to increase synaptic bouton number (Koh et 
al., 2002). We additionally did not observe any growth defects in gen-P/3~80 
(Fig.3.3). These results indicate that Ras is not required for the effects of PI3K on 
synaptic growth. 
Recent work by our lab suggests that the Ca2+/Calmodulin-dependent protein 
kinase II (CaMKII) may act upstream PI3K to mediate arborization (Lin et al., 
2011 ). We and others have demonstrated that CaMKII promotes motor neuron 
arborization (Lin et al., 2011; Beumer et al., 2002; Koh et al., 1999). We also 
found the expression of an active form of PI3K can block the decrease synaptic 
outgrowth conferred by the expression of the CaMKII inhibitory peptide, ala2, 
suggesting that CaMKII inhibition blocks arborization by preventing PI3K 
activation (Lin et al., 2011 ). Alternatively, the activation of PI3K signaling by 
insulin growth factors, which occurs in a Ras-independent manner (Backer et al., 
1992) may also regulate synaptic growth. Neuronal circuits are targets for insulin 
(Barsh and Schwartz, 2002; Konner et al., 2009) and Insulin-like and Insulin 
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Receptor-like immunoreactivity are present at the Drosophila larval nmj (Budnik 
et al., 1990). 
The Ras-ERK pathway was previously shown to participate in synapse 
formation in Drosophila via the modulation of the Discs-Large (DLG)-Fascilin II 
(Fasll) cell adhesion complex (Koh et al., 2002). Fasll, the Drosophila ortholog 
of NCAM (Schuster et al., 1996), and DLG cluster Shaker K+ channels and the 
cytoskeleton, forming a complex that must be disassociated for outgrowth to 
occur (Thomas et al., 1997; Davis et al., 1997; Zito et al., 1997; Tejedor et al., 
1997). In Aplysia, it has been shown that Fasll is phosphorylated by ERK, 
resulting in the internalization of Fasll and the disassociation of the DLG-Fasll 
stabilization complex (Bailey et al., 1997). Similarly in Drosophila, activated ERK 
was observed to displace Fasll at the motor neuron terminus, increasing synaptic 
growth (Koh et al., 2002). Our data also supports that Ras-ERK signaling is 
required for synaptic outgrowth. Similar to what was observed when we knocked 
down Ras, we found that we could significantly reduce motor neuron arborization 
by inhibiting the activity of Raf (Fig.3.3). Interestingly, though we could block the 
synaptic growth defects caused by the expression of ala2 with an active form of 
PI3K (Lin et al., 2011 ), we could not similarly block the growth defects conferred 
by the inhibition of Ras and Raf (Fig.3.3). These results indicate that ERK 
signaling is necessary for the effects of both CamKII and PI3K on synaptic 
growth. 
CaMKII has been previously demonstrated to promote synaptic outgrowth 
removing DLG from the DLG-Fasll complex (Koh et al., 1999), therefore the 
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effect of CaMKII on growth appears to be both direct and indirect via PI3K. The 
inhibition of P13K and CaMKII in the motor neuron reduces synaptic outgrowth 
(Lin et al., 2011; Howlett et al., 2008; Martin-Pena et al., 2006). We have found 
that these defects can be blocked by the expression of an active form of PI3K 
(Lin et al., 2011; Howlett et al., 2008); however, in this study it was observed that 
the synaptic growth defects that occur as a result of inhibiting components of the 
ERK signaling pathway (i.e. Ras and Raf) cannot be similarly rescued by PI3K 
(Fig.3.3). This suggests that Ras-ERK signaling is required for synaptic 
outgrowth. Intact Ras-ERK signaling is also appears to be required for the 
effects of CaMKII and PI3K on synaptic outgrowth. 
These data indicate that parallel pathways cooperate to orchestrate synaptic 
outgrowth. We hypothesize that for bouton growth to occur, the CaMKII and 
Ras-ERK signaling pathways are required to disable the DLG-Fasll complex, 
reducing bouton stabilization, and that the PI3K cascade is necessary to initiate 
protein translation via S6KimTOR (Howlett et al., 2008) (Fig.3.4). The 
observation that Ras-ERK signaling is a requirement for the effects of either 
CaMKII or PI3K on growth indicates that ERK may act on the DLG-Fasll 
stabilization complex in a manner distinct from the effect of activated CaMKII 
(i.e., ERK phosphorylation may more efficiently remove the complex). ERK may 
additionally have other targets distinct from CamKII that are required for this 
process, including the transcription factor CREB, which has been shown to 
participate in neurite outgrowth in cultured sensory cells (Schmid et al., 2001; 
White et al., 2000). 
103 
5.1.3 Functionally distinct pools of PI3K may exist in the Drosophila 
motor neuron 
The motor neurons of the DmGiuRA null mutant, DmG/uRA 112b, are 
significantly hyperexcitable; however, though these mutants have aberrant PI3K 
signaling (Howlett et al., 2008) they exhibit only a slightly reduced number of 
enlarged, synaptic boutons (Bogdanik et al., 2004). Furthermore, we observed 
that gen-P/3~80, which cannot be activated by Ras, increases neuronal 
excitability (indicative of decreased PI3K activity) but elicits wildtype synaptic 
bouton number (indicating wildtype P13K activity). These observations suggest 
that the PI3K activity that is available to regulate excitability is not available to 
influence synaptic growth, raising the possibility that there are pools of PI3K in 
the motor neuron mediating distinct neural processes (Fig.5.1 ). 
Functionally discrete pools of non-diffusible PI3K have been previously 
reported to occur in the dendritic spines of the hippocampus (Man et al., 2003). 
These pools of PI3K are compartmentalized via their association with AMPA 
receptors (Man et al., 2003). Other molecules, including Ca2+, the MAP kinases 
JNK and ERK, and the translational regulator eiF4E have additionally been 
shown to have localized activity in neurons (Asaki et al., 2003; Luttrell, 2002; 
Mulvaney and Roberson, 2000; Mulvaney et al., 1999). These functional pools 
are at least in part due to the spatial localization of these molecules in the cell; 
therefore the pool of PI3K that is activated by DmGiuRA may be spatially 
separated from the PI3K that is activated to promote synaptic growth. The fact 
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that DmGiuRA is not located in the active zones in motor neurons where synaptic 
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Figure 5.1: Functionally discrete pools of PI3K regulate distinct neuronal 
processes. Two functionally discrete pools of PI3K function in Drosophila motor 
nerve terminals. In the first pool, PI3K is activated by glutamate, presumably 
released from motor nerve terminals and acting via DmGiuRA in an autocrine 
pathway. This PI3K activation is Ras dependent and downregulates excitability 
via the Akt-dependent phosphorylation and inhibition of the transcription factor 
dFOXO. CaMKII and DFak activities are also required for this PI3K activation. In 
the second pool, PI3K is activated by unknown means and promotes synaptic 
growth and bouton formation via the S6K-dependent activation of translation. 
This PI3K activation also requires CaMKII and DFak, but not Ras. However, Ras 
participates in synaptic growth and bouton formation via the Raf/Erk-dependent 
phosphorylation and downregulation of Fasll and DLG. The active PI3K found in 
each pool do not appear to be easily interchangeable: Blocking DmGiuRA 
increases neuronal excitability but has only mild effects on synaptic bouton 
number (Bogdanik et al., 2004 ), whereas blocking the ability of Ras to activate 
PI3K increases neuronal excitability but has not effect on synaptic bouton 
number. 
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5.1.4 Proposed model for role of Ras and PI3K in excitability and 
synaptic outgrowth in the Drosophila motor neuron 
The observations described in this document, taken together with our recent, 
published findings by Howlett et al. (2008) and Lin et al. (2011 ), have led us to 
suggest the following mechanism for the activation of PI3K by glutamate-
liganded DmGiuRA at the Drosophila motor neuron nerve terminal (Fig.5.2). In 
this proposed mechanism, DmGiuRA signaling triggers an increase in 
intracellular Ca2+, most likely through PLC and IP3 receptor activation. This Ca2+ 
transient activates the Ca2+/calmodulin-dependent kinase II (CaMKII) which in 
tum, phosphorylates Drosophila Focal adhesion kinase (DFak). Phosphorylated 
DFak then activates PI3K, which downregulates neuronal excitability by the 
inhibition of the Drosophila Forkhead box transcription factor (dFOXO). dFOXO 
might regulate excitability via the transcription of ion channels subunits or 
additional regulators. We have additionally shown that the activation of PI3K 
increases synaptic growth by regulating translation via S6KimTOR signaling. 
The results of this current study now indicate that Ras is additionally involved 
in the activation of PI3K via DmGiuRA-mediated signaling. In vertebrates, both 
Fak and the other Fak family member, Pyk2, have been shown to activate PI3K 
via the pBS-regulatory subunit (Guinebault et al., 1995; Chen and Guan, 1994; 
Chen et al, 1996). Activated Fak and Pyk2 are also capable of activating Ras via 
the conserved Grb2-SoS pathway (Rocic et al., 2001; Dikic et al., 1996; 
Schlaepfer et al., 1994 ); which could lead to the Ras-dependent activation of 
PI3K. These data suggest activated DmGiuRA-mediated signaling could activate 
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Ras via DFak, or that the activation of both DFak and Ras cooperatively bind to 
and activate PI3K (Fig.5.2). Additional experiments need to be performed to 
further examine these possibilities. 
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Figure 5.2: CaMKII, DFak, and Ras are critical signaling intermediates in the 
activation of PI3K downstream DmGiuRA. Based on the findings of this study 
and previous results from our lab (Lin et al., 2011; Howlett et al., 2008), we have 
proposed a model for the initiation of PI3K via glutamate-activated DmGiuRA. 
Glutamate-activation of DmGiuR results in the production of intracellular Ca2+ 
intermediates, most likely through PLC-IP3 signaling. The subsequent increase 
in internal Ca2+ in turn activates the Ca2+/Calmodulin kinase, CaMKII. CaMKII 
activates Drosophila focal adhesion kinase (DFak) which then activates PI3K (Lin 
et al., 2011 ). The activation of PI3K by DFak occurs via Ras or in concert with 
Ras. PI3K phosphorylates and activate Akt (reviewed in Vanhaesebroeck et al., 
2001 ). Activated Akt negatively regulates the activity of the transcription factor 
dFOXO. The downregulation of dFOXO decreases neural excitability in the motor 
neuron (Howlett et al., 2008). The mechanisms by which dFOXO decreases 
excitability are not currently known; however, we postulate that the transcription 
of ion channel subunits or regulators may be involved. The dashed lines indicate 
putative activatory pathways. 
5.2 Role for Ras-PI3K in Drosophila L TO 
5.2.1 PI3K and Ras are involved in L TP 
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Abnonnalities in the processes of long-tenn depression (L TO) and long-tenn 
potentiation (L TP), which modify the strength and efficacy of synaptic 
connections, are linked to significant neurological diseases that have co-
morbidity with autism, including Fragile X Syndrome (FXS) and 
Neurofibromatosis-1 (NF1) (Bourgeois, 2009; Kelleher and Bear, 2008; Li et al., 
2005; Rubenstein and Merzenich, 2003; Costa et al., 2002). L TP is initiated by 
the glutamate-liganded activation and Ca2+ influx through the NMDA subset of 
iGiuRs, triggering several intracellular signaling cascades that potentiate the 
activity of a second iGiuR, AMPA (Bear and Malenka, 1994; Bliss and 
Collingridge, 1993). L TP involves the insertion of the AMPA receptors into the 
postsynaptic membrane, which is believed to sensitize the postsynaptic cell to 
further signaling (Lu et al., 2001). Though the exact mechanisms regulating 
AMPA receptor insertion are still debated, it has been found that the p85-subunit 
of PI3K co-localizes with the glutamate receptor 2 (GiuR2) subunit of the AMPA, 
helping to direct the insertion of the receptor into the membrane (Man et al., 
2003). PI3K signaling is additionally required to maintain the duration of L TP by 
modifying translation via mTOR and p70 S6K (Cammalleri et al., 2003; Karpova 
et al., 2006). A role for PI3K in L TO, defined as the desensitization of a neuron to 
stimuli, has also been established. PI3K signaling, in cooperation with the ERK 
pathway, is activated by the agonist-activation of postsynpatic mGiuRs, coupling 
the activation of the receptor to protein translation during mGiuR-L TO (Antion et 
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al., 2008; Banko et al., 2006; Hou and Klann, 2004). The scaffolding protein 
Homer has been proposed to form a complex with mGiuR and the PI3K-
enhancer, PIKE, during mGiuR-L TO, potentially linking PI3K to mGiuR activation 
(Rong et al., 2003; Ronesi and Huber, 2008). Insulin-induced L TO via NMOA 
receptor activation has additionally been found to require PI3K signaling (van der 
Heide et al., 2005). 
The role of Ras in the modulation of L TP and L TO is much less defined, 
though there is evidence that Ras participates in L TP. Patients with NF1 , 
resulting from a mutation in the Ras-GAP encoding gene, NF1 (Xu et al., 1990), 
are frequently diagnosed with autism which may be a result of perturbations in 
L TP that are observed in mouse models of the disease (Kelleher and Bear, 2008; 
Silva et al., 1997; Costa et al., 2001; Costa et al., 2002; Costa et al., 2005; Li et 
al, 2005; North et al., 2002). Ras may participate in LTP similar to PI3K by 
mediating the insertion of AMPA receptor subunits into the postsynaptic 
membrane (Qin et al., 2005; Zhu et al., 2002). Spontaneous neural activity or low 
levels of induced Ras activity has been observed to potentiate the delivery of the 
GluR2-Iong (GiuR2L) splice variant subunit-containing AMPA receptors to the 
membrane via the Ras-ERK pathway (Qin et al., 2005; Zhu et al., 2002). 
Increased neural activity additionally stimulates Ras-PI3K signaling, mediating 
glutamate receptor 1 (GiuR1) subunit AMPA receptor potentiation (Qin et al., 
2005). The overexpression of Ras was additionally found to block the LTP defect 
in mouse models of FXS via the rescue of AMPA receptor defects (Hu et al., 
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2008). These data indicate a role for Ras in synaptic processes related to L TP; 
however, could Ras also be involved in LTD? 
5.2.2 Ras may be involved in LTD in the Drosophila motor neuron 
The activation of cap-dependent translation during mGiuR-L TO has been 
shown to require the coordinated signaling between two cascades that are 
activated by Ras; the PI3K-mTOR and ERK signaling pathways (Banko et al., 
2006; Gallagher et al., 2004; Antion et al., 2008). G protein-coupled receptors 
have been previously shown to modulate Ras in a variety of cell types (reviewed 
in Goldsmith and Dhanasekaran, 2007). Though it is postulated that Homer 
facilitates the interaction between the group I mGiuRs and PI3K (Rong et al., 
2003; Ronesi and Huber, 2008), it is unclear how this complex activates PI3K; 
therefore a role for Ras in the activation of PI3K can not been entirely ruled out. 
Because the group II mGiuRs do not have a Homer-binding domain (Diagana et 
al., 2002) further raises the possibility that Ras may function as a signaling 
intermediate especially in regards to this mGiuR subtype. In this study we have 
shown that the activation of P13K by the vertebrate group II ortholog in 
Drosophila, DmGiuRA, requires the activity of Ras. Because the altered 
expression of group II mGiuRs have been suggested to contribute to the 
pathophysiology of schizophrenia and epilepsy (Gupta et al., 2005; Aronica et al., 
1997) it is of interest to human health to determine if the pathway components 
related to group II mGiuR-L TD are conserved in vertebrates. 
Several lines of evidence indicate that Ras may be involved in synaptic L TO. 
Firstly, it is important to note that both the electrical and chemical stimulation of 
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the presynaptic group II mGiuRs has been demonstrated to elicit L TO in 
vertebrates (Aitinbilek and Manahan-Vaughan, 2009; Poschel and Manahan-
Vaughan, 2005; Manahan-Vaughan, 1997; Huang et al., 1997). Additionally, the 
activation of group II mGiuR-L TD in the vertebrate hippocampus was additionally 
found to activate ERK, a downstream target of Ras signaling, in the surrounding 
glia and intemeurons of the vertebrate hippocampus (Berkeley and Levey, 2003). 
LTD has been demonstrated to be reliably induced in the presynaptic motor 
neuron of the Drosophila nmj and it was further discovered that a series of Akt 
hypomorphs show impaired LTD (Guo and Zhong, 2006), indicating that PI3K 
signaling may be involved. We have previously demonstrated that neural 
excitability is regulated by the DmGiuRA activation of PI3K-Akt (Howlett et al., 
2008), which we would expect is critical for establishing LTD. We have now 
determined that Ras activity is critical for the effect of PI3K on excitability; 
therefore we proposed that Ras may act upstream PI3K-Akt during L TO in the 
Drosophila motor neuron. 
5.2.3 Ras activity as a target for autism therapeutics 
Hyperactivated PI3K signaling has been linked to many significant 
neurological diseases including FXS, tuberous sclerosis (TSC), and 
Cowden/Lhermitte-Ducols syndrome (Bourgeois, 2009; Kelleher and Bear, 2008; 
Grosset al., 2010; Levitt and Campbell, 2009; Kelleher and Bear, 2008; Williams, 
et al., 2008; Kwon et al., 2006). The use of pharmacological pathway inhibitors, 
including rapamycin, have proven useful for the treatment of the tumors that form 
in conjunction with TSC (Davies et al., 2008) however, the effect of this drug on 
111 
the cognitive defects associated with these diseases is limited and still under 
review (de Vries, 2010). Because PI3K is a ubiquitous signaling molecule 
involved in a multitude of cellular processes throughout the body, it is important 
that future therapeutics can more specifically target aspects of the PI3K pathway 
that are dysregulated in neurons to prevent potential side effects. 
Ras is additionally a ubiquitous molecule; however, in vertebrates there are 
two neural specific Ras guanine exchange factors (Ras-GEFs), Ras guanyl 
nucleotide-releasing protein (Ras-GRP) and the Ras-guanine-nucleotide-
releasing-factor (Ras-GRF), that activate Ras in response to neural activity 
(Ebinu et al., 1998; Farnsworth et al., 1995). These factors are present at 
synapses and appear to be involved in synaptic plasticity (Tian et al., 2004). 
Additionally, the Ras-inhibitor synaptic GTPase-activating protein (SynGAP) is 
also found specifically in vertebrate neurons (Chen et al., 1998). Because we 
have shown that Ras activity is critical for the effect of PI3K on neural excitability, 
drugs that alter the effects of these molecules that are specially expressed in the 
nervous system may be effective in the modulation of the aberrant PI3K signaling 
observed in many neurological disorders related to autism. 
5.3 Future work 
In this study we have demonstrated that the effect of PI3K in the regulation of 
neural excitability is a Ras-dependent process; however, several important 
questions remain that warrant additional investigation. The mechanism by which 
glutamate-liganded DmGiuRA initiates the activation of Ras is not entirely clear. 
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We have shown that CaMKII and DFak are critical DmGiuRA-PI3K signaling 
intermediates (Lin et al., 2011 ). We suspect that DFak may be responsible for the 
activation of Ras; however, we have not clearly demonstrated that Ras is 
epistatic to DFak. The disassociated Ga and Gj3y subunits of activated G 
protein-coupled receptors have been found to activate Ras in a variety of cell 
types (reviewed in Goldsmith and Dhanasekaran, 2007); therefore Ras may be 
activated independently and in parallel with DFak during DmGiuRA-mediated 
signaling. To investigate this possibility, we need to examine the level of p-Akt 
after glutamate application in a series of G protein subunit -RNAi transgenic lines 
that would inhibit the activity of the Ga and Gj3y subunits in the Drosophila motor 
neuron. In addition to potentially disrupting Ras activation, knocking down the 
activity of these subunits may also alter DmGiuRA-CaMKII-DFak signaling; 
therefore we would need to additionally explore the effect of G protein subunit 
RNA-knockdown in the presence of a UAS-DFak construct that would rescue the 
potential effect on this pathway. If the expression of the G protein subunit RNAi in 
the presence of UAS-DFak blocks the glutamate-induced increase in p-Akt then 
we could conclude that Ras is activated via a separate, G protein-receptor-
mediated pathway and that both DFak and Ras are required for the full activation 
of PI3K in response to DmGiuRA activation. 
Ras interacts and activates PI3K via the Ras-binding domain of the catalytic 
unit of PI3K (Rodriguez-Viciana et al., 1994; Rodriguez-Viciana et al., 1996), 
whereas DFak activates PI3K via the p85 (p60 in Drosophila) subunit (Pignataro 
and Ascoli, 1990). To further investigate if DFak is activating PI3K directly or 
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indirectly though Ras, a p60-RNAi could be generated and expressed in the 
motor neuron and the level of p-Akt analyzed. If the expression of p60-RNAi does 
not block the glutamate-induced increase of p-Akt then this would indicate that 
DFak activates PI3K indirectly via Ras. However, if inhibiting p60 does block the 
induction of p-Akt, this would suggest that Ras and DFak independently activate 
PI3K and that both are required for the full activation of PI3K by DmGiuRA. We 
have recently found that the increase in p-Akt after glutamate application is 
blocked in the DFak null mutant, DFalfG1 (Lin et al., 2011 ). To additionally 
determine if Ras is required for the activation of PI3K via DFak, we could 
additionally express UAS-Ras+ in the DFalfG1 background to investigate if Ras 
blocks the DFalfG1 phenotype. If expression of Ras cannot block the DFalfG1 p-
Akt phenotype, then this would suggest that both DFak and Ras are required for 
the activation of PI3K; however, if Ras expression can in fact block the DFalfG1 
phenotype, this would indicate that Ras is required for the activation of PI3K by 
DFak and that Ras is epistatic to DFak during DmGiuRA-mediated signaling. 
Additional experiments that would be of merit to pursue would be an 
investigation of L TO in the Drosophila motor neuron using a series of PI3K and 
Ras transgenic mutants. These studies may validate the role of PI3K and Ras in 
the group II mGiuR-mediated L TO in Drosophila, which may help to elucidate a 
similar pathway in vertebrates. 
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